academic journal | Q737498 |
open-access journal | Q773668 |
scientific journal | Q5633421 |
P6981 | ACNP journal ID | 71801 |
1068976 | ||
2974777 | ||
P8375 | Crossref journal ID | 75722 |
299757 | ||
P1250 | Danish Bibliometric Research Indicator (BFI) SNO/CNO | 5045 |
P5115 | Directory of Open Access Journals ID | 1024-5332 |
1607-8454 | ||
P1058 | ERA Journal ID | 16190 |
P236 | ISSN | 0882-8083 |
1024-5332 | ||
1607-8454 | ||
P1277 | JUFO ID | 56980 |
P1055 | NLM Unique ID | 9708388 |
P10283 | OpenAlex ID | V195061619 |
P3181 | OpenCitations bibliographic resource ID | 64538 |
P7662 | Scilit journal ID | 1258330 |
P1156 | Scopus source ID | 24995 |
95427 |
P1240 | Danish Bibliometric Research Indicator level | 1 | |
P8875 | indexed in bibliographic review | Scopus | Q371467 |
Science Citation Index Expanded | Q104047209 | ||
P123 | publisher | Taylor & Francis | Q880582 |
Maney Publishing | Q6748462 | ||
P1476 | title | Hematology |
Q47404801 | "Pawn Ball Megakaryocytes": from the marvellous medici and dear Old Saint Nick to the unsanctified marrow of myelodysplasia |
Q39672189 | 'Real-life' study of imatinib therapy in chronic phase-chronic myeloid leukemia: A novel retrospective observational longitudinal analysis. |
Q50483826 | 'Reflex' HPLC testing as a screening modality for variant hemoglobins: a pilot study of 1310 cases at a pediatric referral hospital. |
Q46426326 | 2'-Chlorodeoxyadenosine Effectively Induces Complete Remission in Hairy Cell Leukaemia |
Q87899099 | 6-Mercaptopurine, Still Valuable for the Palliative Treatment of Acute Myeloid Leukaemia |
Q40494563 | A 45-year-old male with fever and hepatosplenomegaly |
Q34545640 | A 5-year-old boy with hepatosplenomegaly |
Q46009562 | A BCNU-containing Regimen, Mini-BEAM, with GM-CSF is a Safe and Effective Mobilizing Regimen Pre-stem Cell Transplantation in Lymphoma Patients. |
Q33433875 | A Case of Childhood Anemia Complicated by a Red Cell Membrane Sugar Chain Anomaly with Low Levels of Sialic Acid |
Q87876101 | A Case of Malignant Histiocytosis having Polyploid Clones Characterized by an Isochromosome of the Long Arm of Chromosome 17 [i(17q)] and t(9;22) Translocation |
Q47684195 | A Case of Minimally Differentiated Acute Leukemia (AML-M0) Complicated by Ventricle Thrombosis During Remission-induction |
Q87876099 | A Further Study on the Incidence of Nucleoli in Myeloblasts of Patients Suffering from Acute Myeloid Leukemia |
Q87876105 | A Long-term Remission of a Recurrent Acute Lymphoblastic Leukaemia with Donor Leukocyte Infusions after Allogeneic Peripheral Blood Stem Cell Transplantation |
Q87911021 | A Low CD34+ Cell Dose Predicts Relapse and Death Early following Autologous Blood Stem Cell Transplantation |
Q83903835 | A Mexican way to cope with stem cell grafting |
Q36269948 | A broad and integrated diagnostic work-up for a modern management of Acute Lymphoblastic Leukemia (ALL). |
Q50174928 | A case of congenital dyserythropoietic anemia type II, Gilbert's syndrome and malleolar trophic ulcers. |
Q48226483 | A child with severe iron-deficiency anemia and a complex TMPRSS6 genotype |
Q51009837 | A clinical analysis of primary testicular diffuse large B-cell lymphoma in China. |
Q57655179 | A combination of two novel alpha globin variants Hb Bridlington (HBA1) and Hb Taybe (HBA2) resulting in severe hemolysis, pulmonary hypertension, and death |
Q50697610 | A comparison of conventional tube test and gel technique in evaluation of direct antiglobulin test. |
Q39369214 | A comparison of heart function and arrhythmia in clinically asymptomatic patients with beta thalassemia intermedia and beta thalassemia major |
Q83926734 | A complication of steroid therapy in acute leukaemia--a case report |
Q33436173 | A fatal case of transplantation-mediated alloimmune thrombocytopenia following liver transplantation |
Q106647121 | A five-year retrospective study of treatment outcomes using the L-asparaginase-based regimen as a first-line chemotherapy protocol for patients diagnosed with extranodal NK/T-cell lymphoma, nasal-type, in Thailand |
Q38442230 | A genetic features and gene interaction study for identifying the genes that cause hereditary spherocytosis |
Q46924606 | A killer revealed: 10-year experience with beta-thalassemia intermedia |
Q39174017 | A microplate reader-based method to quantify NADH-cytochrome b5 reductase activity for diagnosis of recessive congenital methaemoglobinemia |
Q96021545 | A multicentre retrospective study of primary breast diffuse large B-cell and high-grade B-cell lymphoma treatment strategies and survival |
Q86542140 | A mutational and expressional analysis of DNMT3A in acute myeloid leukemia cytogenetic subgroups |
Q35670980 | A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria |
Q98512655 | A novel EPB41 p.Trp704* mutation in a Korean patient with hereditary elliptocytosis: a case report |
Q89855111 | A novel compound heterozygous mutation in DGKE in a Chinese patient causes atypical hemolytic uremic syndrome |
Q83063399 | A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis |
Q104470383 | A novel homozygous missense mutation (Met527Ile) in a consanguineous marriage family with inherited factor XII deficiency |
Q102064426 | A novel β-thalassemia variant at HBB:c.14delC (Codon 4, -C) identified via next-generation sequencing |
Q39337522 | A particular expression pattern of CD13 epitope 7H5 in chronic lymphocytic leukaemia--a possible new therapeutic target. |
Q49549984 | A patient with oxaliplatin immune-induced syndrome (OIIS) who also developed leucovorin and palonosetron-associated thrombocytopenia. |
Q40473999 | A phase 1/2 trial of lenalidomide and dexamethasone in adult patients with refractory/relapsed acute lymphoblastic leukemia. |
Q46979566 | A phase II study of thalidomide and vinblastine for palliative patients with Hodgkin's lymphoma. |
Q42199323 | A pilot study of manual chronic partial exchange transfusion in children with sickle disease. |
Q42467301 | A prospective study of the hypothalamic-pituitary-adrenal axis in children with acute lymphoblastic leukemia receiving chemotherapy. |
Q53550692 | A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms. |
Q39156320 | A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation |
Q33386717 | A retrospective analysis of therapeutic responses to two distinct corticosteroids in 259 children with acute primary idiopathic thrombocytopenic purpura |
Q39045544 | A retrospective study of leukemia epidemiology in Northern Tunisia |
Q36194538 | A review of Campath in autoimmune disease: biologic therapy in the gray zone between immunosuppression and immunoablation |
Q35670977 | A review of the molecular diagnosis of thalassemia |
Q39135249 | A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience |
Q85941673 | A risk score for predicting pulmonary hypertension in patients with non-transfusion-dependent thalassemia in northeastern Thailand: The E-SAAN score |
Q36194591 | A role for niches in hematopoietic cell development |
Q45850500 | A self-controlled comparative clinical trial to explore the effectiveness of three topical hemostatic agents for stopping severe epistaxis in pediatrics with inherited coagulopathies |
Q53543239 | A short note on the nuclear diameter in human early granulocytic progenitors. |
Q43014789 | A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule |
Q92329963 | A sporadic MYH9-related disease in a Chinese boy with p.A95T mutation |
Q47374546 | A structure-function analysis in patients with prekallikrein deficiency. |
Q46151236 | A study for evaluation of different diagnostic approaches in acute leukemia in Egypt |
Q80376717 | A summary on the immunophenotyping of acute lymphoblastic leukemia in Thailand |
Q90463316 | A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia |
Q92910694 | A systematic review and meta-analysis of the efficacy and adverse events of azacitidine-plus-lenalidomide treatment for patients with acute myeloid leukemia, myelodysplastic syndromes and chronic myelomonocytic leukemia 1 |
Q90775885 | A triplex probe-based TaqMan qPCR assay for Calreticulin type I and II mutation detection |
Q45918795 | ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells. |
Q57457471 | ADAMTS-13 activity reduction in plasma of acute myeloid leukemia predicts poor prognosis after bone marrow transplantation |
Q51099496 | ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia. |
Q54333318 | AHI1 gene expression levels and BCR-ABL1 T315I mutations in chronic myeloid leukemia patients. |
Q36194560 | AHSP and beta-thalassemia: a possible genetic modifier |
Q39743670 | Aberrant expression of NK cell receptors in Epstein-Barr virus-positive gammadelta T-cell lymphoproliferative disorders |
Q81203951 | Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells |
Q46417608 | Aberration of p73 promoter methylation in de novo myelodysplastic syndrome |
Q33403318 | Abnormal WBC scattergram: a clue to the diagnosis of malaria |
Q33382851 | Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria. |
Q92590626 | Abnormalities of quantities and functions of CD56bright natural killer cells in non-severe aplastic Anemia |
Q38896394 | Abnormalities of the p53 Tumour Suppressor Gene in Mature B-cell Neoplasms |
Q92727044 | Abstracts for issue YHEM 21 : S1 |
Q46984091 | Acquired Aplasia of the Bone Marrow |
Q36328387 | Acquired coagulation inhibitor-associated bleeding disorders: an update |
Q46411395 | Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency |
Q36307579 | Acquired haemoglobin H disease |
Q36497382 | Acquired hemophilia A. |
Q36356147 | Acquired hemophilia A: a review of recent data and new therapeutic options |
Q36194596 | Acquired red cell aplasia in association with the use of recombinant erythropoietin in chronic renal failure |
Q84559367 | Acquired von Willebrand syndrome in multiple myeloma |
Q87878034 | Activated Cellular Immunity in Chronic Hepatitis C |
Q48910385 | Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes. |
Q87876324 | Acute Colonic Graft-versus-host Disease and Ulcerative Colitis with Respect to Cytokines |
Q87879361 | Acute Lymphoblastic Leukemia Occurring in a Case of Chronic Lymphocytic Leukemia |
Q47618487 | Acute Myeloblastic Leukemia: Management with High-Dose Cytosine Arabinoside, Daunorubicin and Marrow Transplantation; Malignancy; Current Clinical Practice. |
Q87911774 | Acute Myelogenous Leukaemia in Patients 60 Years and Older: A Retrospective Analysis from St Bartholomew's Hospital 1969-1999 |
Q38896517 | Acute Myocardial Infarction in Sickle Cell Disease: Case Report and Review of the Literature |
Q38894046 | Acute Normovolemic Hemodilution in Surgery |
Q87924331 | Acute Promyelocytic Leukemia in Late Pregnancy. Successful Treatment with All-Trans-Retinoic Acid (ATRA) and Chemotherapy |
Q41415693 | Acute leukemia in adults: novel allogeneic transplant strategies |
Q35809438 | Acute leukemia subclassification: a marker protein expression perspective |
Q46830755 | Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition. |
Q86035795 | Acute myeloid leukaemia |
Q89077060 | Acute myeloid leukemia carrying ETV6 mutations: biologic and clinical features |
Q41439053 | Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3. |
Q44219898 | Acute physiological responses to physiotherapy applications pre and post autologous stem cell transplantation: an experimental study |
Q35127005 | Acute promyelocytic leukemia: a case-based review. |
Q36270144 | Acute promyelocytic leukemia: a model of molecular target based therapy. |
Q43910279 | Acute respiratory distress syndrome in patients with hematological malignancies |
Q45866634 | Adherence to clotting factors among persons with hemophilia A or B. |
Q87875750 | Adhesion and Transendothelial Migration of Human Monocytes: Role of Cytokine (IL3, GM-CSF) Activated Endothelial Cells |
Q42496327 | Adhesion of B-Cell Chronic Lymphocytic Leukemia Cells to Marrow Stromal Cells is Mediated by α4β1 but not β2αL Integrin: MSC also Prevent Apoptosis of B-CLL Cells |
Q41073905 | Adhesion of Hematopoietic Precursors to Human Stroma: Studies Using Normal Marrow Stromal Myofibroblasts and a Stromal Cell Line Transformed by SV40. |
Q84917056 | Adipogenic differentiation alters the immunoregulatory property of mesenchymal stem cells through BAFF secretion |
Q87912677 | Adjuvant Radiotherapy to Initial Bulky Disease in Patients with Advanced Stage Hodgkin's Disease |
Q91628712 | Adjuvant radiotherapy and chemotherapy in early-stage diffuse large B cell lymphoma of head and neck with extranodal involvement |
Q50025361 | Adjuvant radiotherapy in patients with diffuse large B-cell lymphoma in advanced stage (III/IV) improves the outcome in the rituximab era. |
Q34875170 | Adoptive cellular therapy: a therapeutic reality? |
Q55240614 | Adult T-Cell Leukaemia-Lymphoma Relapsing as Hodgkin Disease Nodular Sclerosis Subtype. |
Q83903727 | Adult T-cell leukemia-lymphoma |
Q33358032 | Adult idiopathic thrombocytopenic purpura |
Q33433923 | Advances in Platelet Counting |
Q36687984 | Advances in the diagnosis and management of von Willebrand disease |
Q33435590 | Advances in the pathophysiology of primary immune thrombocytopenia |
Q91892793 | Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma |
Q46830757 | Agnogenic myeloid metaplasia with pulmonary hematopoiesis |
Q40122089 | All-trans retinoic acid attacks reverse transcriptase resulting in inhibition of HIV-1 replication |
Q39471124 | Allelic polymorphisms of human platelets-specific alloantigens in South Tunisian population. |
Q38080144 | Alloantibodies in previously untreated hemophilia A patients: the role of environmental factors |
Q38226100 | Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond. |
Q40766061 | Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: Experience of the Argentinean Group of Bone Marrow Transplantation (GATMO). |
Q83903710 | Allogeneic transplantation for aplastic anemia |
Q36269924 | Allogeneic transplantation for chronic myelogenous leukemia |
Q50574601 | Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. |
Q35008715 | Alpha globin gene numbers: an important modifier of HbE/beta thalassemia |
Q58907737 | Alpha thalassemia gene mutations in neonates from Mazandaran, Iran, 2012 |
Q44935678 | Alteration of the gene expression profile of T-cell receptor αβ-modified T-cells with diffuse large B-cell lymphoma specificity |
Q37293525 | Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseases |
Q42631438 | Alterations of hemostasis after laparoscopic and open surgery |
Q33407813 | Alternate considerations for current concepts in ITP. |
Q39974781 | Alternative salvage regimens for relapsed/refractory classical Hodgkin's lymphoma |
Q54200188 | Among a panel of polymorphisms in genes related to oxidative stress, CAT-262 C>T, GPX1 Pro198Leu and GSTP1 Ile105Val influence the risk of developing BCR-ABL negative myeloproliferative neoplasms. |
Q28274310 | Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27Kip1 and an aggressive clinical course in multiple myeloma |
Q80205154 | Amyloidosis: a changing clinical perspective |
Q104682097 | An aberrant F8 intron 1 inversion with concomitant large duplication and deletion in a Chinese severe hemophilia A patient |
Q54423844 | An anti-apoptotic pattern correlates with multidrug resistance in acute myeloid leukemia patients: a comparative study of active caspase-3, cleaved PARPs, Bcl-2, Survivin and MDR1 gene. |
Q53092886 | An inter-laboratory comparison of PNH clone detection by high-sensitivity flow cytometry in a Russian cohort. |
Q45402341 | An unusual case of autoimmune hemolytic anemia in treatment naïve hepatitis C virus infection |
Q37791615 | An update on disordered iron metabolism and iron overload |
Q28307195 | Anagrelide for the treatment of essential thrombocythemia: a survey among European hematologists/oncologists |
Q47776224 | Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases |
Q42288604 | Analysis of clinical characteristics of 516 patients with non-Hodgkin's lymphoma in Shanghai area |
Q88289712 | Analysis of erythrocyte membrane proteins in patients with hereditary spherocytosis and other types of haemolytic anaemia |
Q104749502 | Analysis of gamma-glutamyltransferase in acute promyelocytic leukemia patients undergoing arsenic trioxide treatment |
Q91964192 | Analysis of gene mutation characteristics in patients with chronic neutrophilic leukaemia |
Q36069486 | Analysis of hemochromatosis gene mutations in 52 consecutive patients with polycythemia vera |
Q91538778 | Analysis of long non-coding RNA expression in hemophilia A patients |
Q98154390 | Analysis of rare thalassemia caused by HS-40 regulatory site deletion |
Q80559469 | Anemia and hemoglobinopathies in tribal population of Eastern and North-eastern India |
Q37737810 | Anemia and transfusions in geriatric patients: a time for evaluation |
Q92157281 | Anemia in centenarians: prevalence and association with kidney function |
Q38199176 | Anemia in malignancies: pathogenetic and diagnostic considerations. |
Q38160129 | Angiogenesis and acute myeloid leukemia |
Q36194525 | Angiogenesis and hematological malignancies |
Q46377195 | Angiogenesis factor pattern differs in acute lymphoblastic leukemia and chronic lymphocytic leukemia. |
Q36069477 | Angiogenic switch in multiple myeloma. |
Q44803743 | Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features |
Q87341345 | Angiopoietins in the bone marrow microenvironment of acute lymphoblastic leukemia |
Q58134838 | Announcement - Foro Latino Americano |
Q58134835 | Announcement - Young Investigator Awards |
Q48097208 | Anthropometric measurements in children having transfusion-dependent beta thalassemia. |
Q36307590 | Anti HCV seroprevalence among the voluntary blood donors in Thailand |
Q33433889 | Anti-Hepatitis C Virus Serology in Immune Thrombocytopenia: A Retrospective Analysis in 101 Patients |
Q85680371 | Anti-carbonic anhydrase antibodies in iron deficiency anemia |
Q38342043 | Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis |
Q50047415 | Antineoplastic chemotherapy in Jehovah's Witness patients with acute myelogenous leukemia refusing blood products - a matched pair analysis. |
Q33433833 | Antiphospholipid Antibodies and Associated Clinical Manifestations |
Q46830752 | Antiphospholipid antibodies and platelet activation as risk factors for thrombosis in thrombocythaemia |
Q81271157 | Antiphospholipid antibody syndrome |
Q33386712 | Antiplatelet antibodies contribute to thrombocytopenia associated with chronic hepatitis C virus infection |
Q38362937 | Antisense Oligonucleotides: Considerations for Lymphoma Therapy |
Q87052921 | Aplastic anaemia |
Q87189127 | Apolipoproteins A1, B, and other prognostic biochemical cardiovascular risk factors in patients with beta-thalassemia major |
Q36194530 | Apoptosis and immaturity in acute myeloid leukemia |
Q53528286 | Apoptosis and proliferation differences between CD34+ and CD34- leukemic subpopulations in childhood acute leukemia. |
Q81243501 | Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea |
Q74000800 | Application of Resistance Reversal Agents in Hematologic Malignancies; Malignancy; Current Clinical Practice |
Q50711111 | Application of flow cytometry in detection of red-cell-bound IgG in Coombs-negative AIHA. |
Q35126995 | Application of the Molecular Analysis of the T-Cell Receptor Repertoire in the Study of Immune-Mediated Hematologic Diseases |
Q50574603 | Are serum nitric oxide and vascular endothelial growth factor levels affected by packed red blood cell transfusions? |
Q33433827 | Are there "Attenuated" Forms of Evans Syndrome? |
Q45204114 | Arginine supplementation improves rotorod performance in sickle transgenic mice |
Q39066853 | Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines |
Q40001380 | Arsenic trioxide-based therapy is suitable for patients with psoriasis-associated acute promyelocytic leukemia - A retrospective clinical study |
Q36194579 | Arsenic trioxide: an anti cancer missile with multiple warheads. |
Q79358889 | Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis |
Q30351531 | Artificial intelligence in hematology. |
Q47683400 | Assessment of Apoptosis Regulating Factors BCL-2 and Fas Antigens on Malignant and Normal Plasma Cells. |
Q54135363 | Assessment of Clonality and Its Relevance in Acute Myeloid Leukaemia and Bone Marrow Transplantation. |
Q87903678 | Assessment of Prognostic Factors in 102 Patients with Myelodysplastic Syndrome-Osteoblasts are Related to Survival |
Q33440206 | Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model |
Q47327066 | Assessment of bcl-2 expression as modulator of fas mediated apoptosis in acute leukemia. |
Q88383496 | Assessment of liver and cardiac iron overload using MRI in patients with chronic anemias in Latin American countries: results from ASIMILA study |
Q44545376 | Assessment of neutrophil apoptosis ex vivo in hepatosplenic patients with neutropenia pre and post splenectomy. |
Q46934229 | Association between Duffy antigen receptor expression and disease severity in sickle cell disease patients. |
Q28248522 | Association between NOD2 single nucleotide polymorphisms and Grade III-IV acute graft-versus-host disease: A meta-analysis |
Q51759896 | Association between acute graft versus host disease and lung injury after allogeneic haematopoietic stem cell transplantation. |
Q51020565 | Association between endothelial dysfunction and otoneurological symptoms in children with sickle cell disease. |
Q86415316 | Association between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiency |
Q96583328 | Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease |
Q35223500 | Association between interleukin-10 promoter gene polymorphisms and acute graft-versus-host disease after hematopoietic stem cell transplantation: a systematic review and meta-analysis |
Q98387832 | Association between sickle cell disease and dental caries: a systematic review and meta-analysis |
Q91628722 | Association between tumor necrosis factor alpha gene polymorphisms and multiple myeloma risk: an updated meta-analysis |
Q90866123 | Association of GSTT1/GSTM1 and ApoE variants with left ventricular diastolic dysfunction in thalassaemia major patients |
Q38991152 | Association of MDR1 gene polymorphism (G2677T) with imatinib response in Egyptian chronic myeloid leukemia patients |
Q44935412 | Association of XRCC1 gene polymorphisms with chronic myeloid leukemia in the population of Andhra Pradesh, India |
Q47669674 | Association of aplastic anemia and FoxP3 gene polymorphisms in Koreans |
Q57466926 | Association of cytotoxic T-lymphocyte antigen 4 gene with immune thrombocytopenia in Chinese Han children |
Q91522447 | Association of diabetes mellitus with non-Hodgkin lymphoma risk: a meta-analysis of cohort studies |
Q40579924 | Association of homocysteine and inflammatory-related molecules in sickle cell anemia |
Q87898614 | Association of human platelet antigen polymorphisms with platelet count and mean platelet volume |
Q34466198 | Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease |
Q39851554 | Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy |
Q40043606 | Associations between the HLA-A/B/DRB1 polymorphisms and aplastic anemia: evidence from 17 case-control studies |
Q89918221 | Atrial fibrillation in beta thalassemia major: how to perform effective screening and early detection |
Q35080336 | Auto-immune haemolytic anaemia--a high-risk disorder for thromboembolism? |
Q57655174 | Autoimmune hemolytic anemia |
Q40484487 | Autoimmune hemolytic anemia in India: clinico-hematological spectrum of 79 cases |
Q33382854 | Autoimmune thrombocytopenia related to chronic hepatitis C virus infection. |
Q33375992 | Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes |
Q44440141 | Autologous Peripheral Blood Stem Cell Transplantation in First Remission Adult Acute Myeloid Leukaemia--An Intention to Treat Analysis and Comparison of Outcome Using a Predictive Model Based on the MRC AML10 Cohort |
Q79839429 | Autologous hematopoietic stem cell transplantation for adults with acute myeloid leukemia in complete remission: the Edouard Herriot Hospital experience |
Q48428886 | Autologous hematopoietic stem cell transplantation for refractory lymphomatoid granulomatosis. |
Q36868599 | Autologous peripheral stem cell transplant for POEMS syndrome: a case report |
Q38859056 | Autophagy governs erythroid differentiation both in vitro and in vivo |
Q39355488 | Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes |
Q36328407 | B cell reductive therapy in the treatment of autoimmune diseases: a focus on monoclonal antibody treatment of rheumatoid arthritis |
Q39241720 | BCL11B suppression does not influence CD34(+) cell differentiation and proliferation |
Q38154292 | BCR-ABL inhibitors: updates in the management of patients with chronic-phase chronic myeloid leukemia |
Q33337686 | BMT: Bone Marrow Transplant Associated Thrombotic Microangiopathy |
Q45877851 | BMT: Fractionation of Gene Modified Hematopoietic Autografts into Multiple Weekly Infusions Does Not Improve Engraftment in Unconditioned Canine Recipients |
Q74000616 | BMT: Serum Ferritin as Risk Factor for Veno-occlusive Disease of the Liver. Prospective Cohort Study |
Q47907052 | Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience |
Q34780626 | Bcl-2 family members as prognostic indicators in AML. |
Q92854354 | Beta-thalassemia: renal complications and mechanisms: a narrative review |
Q88554694 | Better alternatives to permuted block randomization for clinical trials with unequal allocation |
Q50646800 | Beyond diagnosis: subjective theories of illness in adult patients with acute myeloid leukemia. |
Q38006844 | Beyond patient benefit: clinical development in hemophilia. |
Q50711125 | Bias-corrected diagnostic performance of the naked-eye single-tube red-cell osmotic fragility test (NESTROFT): an effective screening tool for beta-thalassemia. |
Q86075610 | Bioinformatics analysis of gene expression profiles in childhood B-precursor acute lymphoblastic leukemia |
Q39962163 | Bioinformatics analysis of molecular mechanism of the expansion of hematopoietic stem cell transduced by HOXB4/HOXC4. |
Q36270075 | Biology and prognostic factors in CLL. |
Q46328753 | Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children |
Q33400768 | Bleeding in the antiphospholipid syndrome |
Q45840460 | Bleeding manifestations apparently unrelated to coagulation or other organic disorders: A tentative classification and diagnostic clues |
Q50905261 | Bleeding manifestations in heterozygotes with congenital FVII deficiency: a comparison with unaffected family members during a long observation period. |
Q33371428 | Bleeding manifestations in severely thrombocytopenic children with immune thrombocytopenic purpura |
Q102064404 | Blockade of PLD1 potentiates the antitumor effects of bortezomib in multiple myeloma cells by inhibiting the mTOR/NF-κB signal pathway |
Q36269972 | Blood transfusion and alternatives in elderly, malignancy and chronic disease |
Q47211906 | Blood transfusion versus hydroxyurea in beta-thalassemia in Iran: a cost-effectiveness study. |
Q59312604 | Bone Marrow Transplantation: Prognostic Factors of Peripheral Blood Stem Cell Mobilization with Cyclophosphamide and Filgrastim (r-metHuG-CSF): The CD34+ Cell Dose Positively Affects the Time to Hematopoietic Recovery and Supportive Requirements afte |
Q34278284 | Bone Marrow TransplantationCurrent Clinical Practice: High-Dose Chemotherapy and Stem Cell Transplantation for Non-Hodgkin's Lymphoma: Review of Recent Advances |
Q82835019 | Bone involvement in pediatric non-Hodgkin's lymphomas |
Q33358037 | Bone marrow and peripheral blood C-kit ligand concentrations in patients with thrombocytosis and thrombocytopenia. |
Q45767936 | Bone marrow angiogenesis in aplastic anemia--a study of CD 34 and VEGF expression in bone marrow biopsies |
Q83903715 | Bone marrow failure and the new telomere diseases: practice and research |
Q53666308 | Bone marrow fibrosis may be an effective independent predictor of the 'TKI drug response level' in chronic myeloid leukemia. |
Q86878728 | Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia |
Q85071744 | Bone marrow metastasis by solid tumors--probable hematological indicators and comparison of bone marrow aspirate, touch imprint and trephine biopsy |
Q38125795 | Bone marrow neoplastic niche in leukemia |
Q80454234 | Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma |
Q33396250 | Bortezomib in patients with renal impairment |
Q42252921 | Brain abscess caused by Nocardia cyriacigeorgica in two patients with multiple myeloma: novel agents, new spectrum of infections |
Q38003011 | Breakthroughs in myeloproliferative neoplasms |
Q40455179 | Breast lump as an initial manifestation in acute lymphoblastic leukemia: an unusual presentation. A case report. |
Q39477239 | Bypassing the maturation arrest in myeloid cell line U937 by over-expression of microRNA-424. |
Q37125164 | C-C motif ligand 11 reduction in CLL patients serum after vitamin D supplementation |
Q44488860 | C950T and C1181G osteoprotegerin gene polymorphisms in myeloma bone disease |
Q48223642 | CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms. |
Q45154626 | CD133-2 (AC141) expression analysis in acute leukemia immunophenotyping in correlation to CD34 and P-glycoprotein |
Q84289192 | CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value |
Q40376093 | CD25 as an adverse prognostic factor in elderly patients with acute myeloid leukemia |
Q38894006 | CD34 Selection and EX Vivo Expansion of Haemopoietic Progenitor Cells: A Review of Laboratory Methodology |
Q36194534 | CD38 as a prognostic marker in CLL. |
Q84429880 | CD56-positive diffuse large B-cell lymphoma: possible association with extranodal involvement and bcl-6 expression |
Q38884580 | CEBPA gene mutations in Egyptian acute myeloid leukemia patients: impact on prognosis |
Q80454240 | CMED in the treatment of nasal natural killer cell lymphoma with distant metastases |
Q57214187 | CML treatment in Asia-Pacific region |
Q46870842 | CUPRAC-BCS and antioxidant activity assays as reliable markers of antioxidant capacity in erythrocytes |
Q52665138 | Calreticulin mutation analysis in non-mutated Janus kinase 2 essential thrombocythemia patients in Chiang Mai University: analysis of three methods and clinical correlations. |
Q49072427 | Calreticulin mutation profile in Indian patients with primary myelofibrosis. |
Q48212811 | Can biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies? |
Q50574609 | Can ischemia-modified albumin be a valuable indicator of tissue ischemia in polycythemia vera? |
Q46290162 | Can mean platelet component be used as an index of platelet activity in stable coronary artery disease? |
Q86396872 | Can threshold for MPO by flow cytometry be reduced in classifying acute leukaemia? A comparison of flow cytometric and cytochemical myeloperoxidase using different flow cytometric cut-offs |
Q35126987 | Cancer Therapy: New Targets for Chemotherapy |
Q81271293 | Cancer and the treatment: does it make sense to patients? |
Q47364092 | Cardiovascular events during carfilzomib therapy for relapsed myeloma: practical management aspects from two case studies |
Q38034291 | Carrier detection for beta-thalassemia trait in general Pakistani population: a way forward |
Q33425012 | Case study of remission in adults with immune thrombocytopenia following cessation of treatment with the thrombopoietin mimetic romiplostim |
Q28300792 | Causes and consequences of the autoimmune lymphoproliferative syndrome |
Q51742405 | Causes of microcytic anaemia and evaluation of conventional laboratory parameters in the differentiation of erythrocytic microcytosis in blood donors candidates. |
Q54123650 | Cell proliferation and inhibition of apoptosis are related to c-Kit activation in leukaemic lymphoblasts. |
Q81409256 | Cell viability of acute myeloid leukaemia blasts in culture correlates with treatment outcome |
Q45242524 | Central nervous system bleeding in pediatric patients with factor XIII deficiency: a study on 23 new cases |
Q37293534 | Central nervous system involvement in adult acute lymphoblastic leukemia |
Q87920481 | Cephalosporin-induced Hemolytic Anemia in a Sicilian Child |
Q74000786 | Cephalosporin-induced Hemolytic Anemia in a Sicilian Child; Erythropoiesis |
Q46302985 | Challenges in the management of sickle cell disease during pregnancy in Senegal, West Africa. |
Q46002196 | Change in expression pattern of TCR-CD3 complex in patients with multiple myeloma. |
Q87282614 | Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients |
Q40002190 | Changes in blood product utilization in a seven-hospital system after the implementation of a patient blood management program: A 9-year follow-up |
Q80677029 | Changes of human B and B-1a peripheral blood lymphocytes with age |
Q33441053 | Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study |
Q44561492 | Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia |
Q48181857 | Characteristics of bone marrow cell dysplasia and its effectiveness in diagnosing myelodysplastic syndrome |
Q88559393 | Characteristics of fibrinolytic disorders in acute promyelocytic leukemia |
Q47624350 | Characterization of Bone Marrow Stromal Cells. |
Q44608849 | Characterization of Clonogenic Progenitors in Autologous Peripheral Blood Stem Cell Grafts: Evaluation of a Simple In Vitro Assay Suitable for Routine Clinical Use |
Q43620861 | Characterization of conserved CDR3 sequence of TCR alpha- and beta-chain genes in peripheral blood T-cells from patients with diffuse large B-cell lymphoma |
Q87876091 | Chromosome 7 and Haematological Malignancies |
Q36270036 | Chromosome copy number and leukemia-lessons from Down's syndrome |
Q87879331 | Chronic Lymphocytic Leukemia: An Update on Current Treatment Approaches |
Q87896115 | Chronic Myeloid Leukemia: Current Guidelines for Diagnosis and Management |
Q80376709 | Chronic graft-versus-host disease after reduced-intensity stem cell transplantation versus conventional hematopoietic stem cell transplantation |
Q33404481 | Chronic immune thrombocytopenic purpura in childhood: pathogenetic mechanisms and management |
Q33343670 | Chronic lymphocytic leukaemia--the haematologic basis for diagnosis and treatment |
Q87173907 | Chronic lymphocytic leukemia |
Q33375516 | Chronic lymphocytic leukemia in India--a clinico-hematological profile |
Q46214120 | Chronic myeloid leukaemia in South Africa. |
Q87655649 | Chronic neutropenia |
Q40697247 | Chronic persistent parvovirus B19 bone marrow infection resulting in transfusion-dependent pure red cell aplasia in multiple myeloma after allogeneic haematopoietic stem cell transplantation and severe graft versus host disease |
Q79125132 | Circulating Blasts Following Chemotherapy in Pediatric Patients: Implications for Complete Remission Definition in Acute Leukemia |
Q53433792 | Circulating T cells derived from acute leukemia patients with severe therapy-induced cytopenia express a wide range of chemokine receptors. |
Q80454221 | Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complex |
Q44108311 | Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences |
Q74597209 | Circulating thrombopoietin in clonal versus reactive thrombocytosis |
Q87367116 | Clearance of donor cell leukemia by means of graft versus leukemia effect: A case report |
Q38896677 | Clinical Applications of Automated Reticulocyte Indices |
Q87896117 | Clinical Regression and Remission of Primary Refractory Angiocentric Lymphoma Following Autologous Tumour Peptide Antigen-charged Dendritic Cells After High-dose Chemotherapy and Autologous Stem Cell Rescue |
Q97540800 | Clinical analysis and literature review of a case with the myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis |
Q51061264 | Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients. |
Q44765612 | Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia |
Q38399929 | Clinical and pathological features of head and neck follicular dendritic cell sarcoma |
Q39851532 | Clinical characteristics and long-term outcomes of warm-type autoimmune hemolytic anemia. |
Q47568416 | Clinical characteristics and outcome of childhood acute promyelocitic leukemia (APL) in Saudi Arabia: a multicenter SAPHOS leukemia group study |
Q90181016 | Clinical characteristics and prognostic factors in Chinese patients with classical Hodgkin's lymphoma involving extranodal sites: a retrospective single-center |
Q92680673 | Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: a retrospective study |
Q103720497 | Clinical characteristics and prognostic study of adult acute myeloid leukemia patients with ASXL1 mutations |
Q30252222 | Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years. |
Q40692620 | Clinical efficacy and safety of ruxolitinib in the management of myelofibrosis: A single institution experience in Taiwan |
Q89530499 | Clinical features and prognosis of normal karyotype acute myeloid leukemia pediatric patients with WT1 mutations: an analysis based on TCGA database |
Q50697626 | Clinical features and risk factors of pure red cell aplasia following major ABO-incompatible allogeneic hematopoietic stem cell transplantation. |
Q45227780 | Clinical features of de novo CD25(+) diffuse large B-cell lymphoma |
Q50631404 | Clinical impact of SNP of P53 genes pathway on the adult AML patients. |
Q35809452 | Clinical implications of T cell receptor repertoire analysis after allogeneic stem cell transplantation |
Q92910684 | Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero |
Q52730056 | Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement. |
Q84559374 | Clinical profile and outcome of urotheliotropic viral haemorrhagic cystitis following haematopoietic stem cell transplantation: a 7-year tertiary centre analysis |
Q54452862 | Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders. |
Q87432673 | Clinical significance of interleukin-22 in multiple myeloma |
Q40426902 | Clinical significance of the ABCB1 and ABCG2 gene expression levels in acute lymphoblastic leukemia. |
Q50736205 | Clinical usefulness of FDG-PET/CT for the evaluation of various types of adult T-cell leukemia. |
Q118149852 | Clinical utility of the updated European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and the Mycoses Study Group Education and Research Consortium computed tomog |
Q91686153 | Clinical variability and molecular characterization of Hbs/Gγ (Aγδβ)0-thal and Hbs/HPFH in Indian sickle cell disease patients: AIIMS experience |
Q43173260 | Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population |
Q36270096 | Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyond |
Q51035365 | Clinico-haematological profile of HbE syndrome in adults and children. |
Q45985682 | Clinico-hematological profile of hereditary spherocytosis: experience from a tertiary care center in North India. |
Q40318435 | Clinicohaematological profile of infections in bone marrow - single centre experience in North Himalayan region of India |
Q41466915 | Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosis |
Q91892902 | Clinicopathologic significance and therapeutic implication of de novo CD5+ diffuse large B-cell lymphoma |
Q91925252 | Clonal evolution in a chronic neutrophilic leukemia patient |
Q53528275 | Clonal evolution with +11q 13, t(1;7) and t(1;4) at relapse in a patient with Ph positive acute lymphocytic leukemia (ALL) treated with single agent front line imatinib followed by dasatinib. |
Q80376747 | Clonal expanded TCR Vbeta T cells in patients with APL |
Q84118966 | Clonal expanded TRA and TRB subfamily T cells in peripheral blood from patients with diffuse large B-cell lymphoma |
Q46639199 | Clonogenic growth patterns correlate with chemotherapy response in acute myeloid leukaemia |
Q35605112 | Clopidogrel: interactions with the P2Y12 receptor and clinical relevance |
Q45856286 | Co-expression of B7-1 with Interleukin-12 Enhances Vaccine-induced Antitumour Immunity in Experimental Myeloma |
Q47441469 | Co-inheritance of HBB:c.-106G > C, a rare single nucleotide variation at position -56 relative to transcription initiation site, with other known mutations in the globin clusters |
Q81409273 | Co-inheritance of alpha-and beta-thalassemia in Khuzestan Province, Iran |
Q38855974 | Coagulation disorders and inhibitors of coagulation in children from Mansoura, Egypt |
Q46600565 | Coagulopathy, following medical therapy, for carcinoma of the prostate |
Q47683726 | Coexistence of Polycythaemia Vera with Indolent Myeloma in the same Patient |
Q87875742 | Coexistent Polycythemia Vera and Chronic Lymphocytic Leukemia: Down-Regulation of Myeloid Clone by the Lymphoid Clone? |
Q89547264 | Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients |
Q80205130 | Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy |
Q33429973 | Combination of low-dose imatinib plus nilotinib for the treatment of chronic-phase chronic myeloid leukaemia after imatinib failure |
Q42878312 | Combination of the histone deacetylase inhibitor valproic acid with oral hydroxyurea or 6-mercaptopurin can be safe and effective in patients with advanced acute myeloid leukaemia--a report of five cases |
Q38798789 | Combined chemotherapy for acute promyelocytic leukemia: a meta-analysis |
Q36269980 | Combined use of oral chelators and desferrioxamine in thalassemia. |
Q47618462 | Commentary of Involvement of E-Cadherin in the Development of Erythroid Cells, Armeneau et al. |
Q90732492 | Common themes and challenges in hemophilia care: a multinational perspective |
Q86429056 | Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction |
Q87903674 | Comparative Study of FISH, PCR and Cytogenetics on 25 Patients Submitted to Bone Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML); Which Tests can we Use in Routine Analysis Post BMT? |
Q33434838 | Comparative analysis of iron status and other hematological parameters in preeclampsia. |
Q62090477 | Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation |
Q47429711 | Comparative evaluation of oral and dento-maxillofacial manifestation of patients with sickle cell diseases and beta thalassemia major |
Q39198051 | Comparative haematological parameters of HbAA and HbAS genotype children infected with Plasmodium falciparum malaria in Yemen |
Q91110925 | Comparative study of bone marrow and blood plasma levels of IL-2 in aplastic anaemia and their relationship with disease severity |
Q84289223 | Comparative study of hypogonadism in beta-thalassemia intermedia patients with and without hydroxyurea |
Q61913903 | Comparing techniques: the use of recalcified plasma in comparison with citrated plasma alone and in combination with thrombin in ultrastructural studies |
Q46600586 | Comparison for functional aberration of G-6-PD deficiency variants with exon 10 mutations |
Q87879592 | Comparison of Rai and Binet Classifications in Chronic Lymphocytic Leukemia |
Q104749499 | Comparison of autologous and allogeneic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia |
Q40895560 | Comparison of clinical trial versus non-clinical trial treatment outcomes of childhood acute lymphoblastic leukemia using comparable regimens |
Q81203967 | Comparison of cost effectiveness between measuring the serum erythropoietin level and reticulocyte count for monitoring thalassemic patients: a note in Thai beta thalassemia/Hb E subjects |
Q39794860 | Comparison of diagnostic criteria for polycythaemia vera |
Q50485190 | Comparison of discriminative indices for iron deficiency anemia and β thalassemia trait in a Brazilian population. |
Q35989647 | Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas |
Q52631905 | Comparison of the efficacy of parenteral and oral treatment for nutritional vitamin B12 deficiency in children. |
Q84559362 | Comparison of working formulation and REAL classification of non-Hodgkin's lymphoma: an analysis of 52 cases |
Q53650174 | Complete resolution of hepatic aspergillosis after non-myeloablative hematopoietic stem cell transplantation in a patient with acute myeloid leukemia. |
Q86052595 | Compliance and satisfaction with deferasirox (Exjade®) compared with deferoxamine in patients with transfusion-dependent beta-thalassemia |
Q37149765 | Complications of sickle cell anaemia in children in Northwestern Tanzania |
Q92725016 | Compound heterozygous mutations Glu502Lys and Met527Thr of the FXII gene in a patient with factor XII deficiency |
Q45878579 | Comprehensive care in hemophilia |
Q97434323 | Comprehensive screening for coexisting heterozygous α0-thalassemia in hemoglobin E trait |
Q47618454 | Concluding Annotation to Armeneau et al. |
Q47622084 | Concluding Annotation to Hahn et al. |
Q47622110 | Concluding Annotation to Ploemacher et al. |
Q47618472 | Concluding Annotation to Torensma et al. |
Q33413602 | Concomitant use of argatroban and warfarin during hemodialysis in heparin-induced thrombocytopenia |
Q46466971 | Concurrent audit of fresh frozen plasma: experience of a tertiary care hospital |
Q44299199 | Concurrent rearrangements of BCL2, BCL3, and BCL11A genes in atypical chronic lymphocytic leukemia |
Q36270161 | Congenital bone marrow failure involving the red blood cells |
Q42216426 | Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → G mutation, and pseudo-Gaucher cells in two siblings. |
Q40001157 | Congenital factor XI and factor VII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: An intriguing observation |
Q90757775 | Congenital fibrinogen disorder caused by digenic mutations of the FGA and FGB genes |
Q81271283 | Congenital neutropenias |
Q53132506 | Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed. |
Q88284783 | Contrasting co-inheritance of alpha and beta mutations in delta beta thalassemia and hereditary persistence of fetal hemoglobin: a study from India |
Q63240981 | Contributions of a regional approach to document hematologic disease in Mexico: a 10-year experience in an open population |
Q87875754 | Controversies Around Vitamin B12 in Sweden |
Q83903830 | Cord blood banking: current status |
Q81474341 | Cord blood transplantation and cord blood banking |
Q95407249 | Correction |
Q95410273 | Correction |
Q91165529 | Correlation between RBC changes and coagulation parameters in high altitude population |
Q58814522 | Correlation between bone mineral densitometry and liver/heart iron overload evaluated by quantitative T2* MRI |
Q43980276 | Correlation between flow cytometric identification of CD33-positive cells and morphological evaluation of myeloblasts in bone marrow of patients with acute myeloblastic leukemia |
Q54399795 | Correlation of beta-thalassemia mutations with alpha-thalassemia: an experience of the southwestern region of Iran. |
Q87912689 | Correlations Between Iron Status Markers During Normal Pregnancy in Women with and without Iron Supplementation |
Q88671797 | Corrigendum |
Q89229913 | Corrigendum |
Q89917867 | Corrigendum |
Q95364100 | Corrigendum |
Q95423099 | Corrigendum |
Q95614402 | Corrigendum |
Q40643748 | Cost Effectiveness of G:CSF in Chemotherapy and Transplant-related Neutropenia |
Q98780081 | Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab |
Q46556375 | Could mean platelet volume be a predictive marker for gestational diabetes mellitus? |
Q43649407 | CpG island methylator phenotype and its relationship with prognosis in adult acute leukemia patients |
Q91058801 | Cross-sectional physician survey on the use of minimal residual disease testing in the management of pediatric and adult patients with acute lymphoblastic leukemia |
Q63241039 | Cultural factors related to adherence to imatinib in CML: A Mexican perspective |
Q39908969 | Curcumin inhibits proliferation and induces apoptosis of leukemic cells expressing wild-type or T315I-BCR-ABL and prolongs survival of mice with acute lymphoblastic leukemia |
Q35126998 | Current Clinical Practice DIC 2002: A Review of Disseminated Intravascular Coagulation |
Q47683100 | Current Clinical Practice: Application of Resistance Reversal Agents in Hematologic Malignancies |
Q54394972 | Current Clinical Practice: Current Management of Thrombotic Thrombocytopenic Purpura. |
Q46861704 | Current Clinical Practice: Hereditary Haemochromatosis: Recent Advances in Biology and Management |
Q47273612 | Current Clinical Practice: Low-Molecular-Weight Heparins in The Prophylaxis and Treatment of Thrombo-Embolic Disease |
Q38897813 | Current Management in Sickle Cell Disease |
Q74000705 | Current Perspectives on the Use of Growth Factors in the Therapy of Acute Myeloid Leukaemia; Malignancy |
Q38894036 | Current Practice in the Treatment of Haemophilia |
Q38897680 | Current Treatment of Chronic Myeloid Leukemia |
Q46541276 | Current treatment practices for essential thrombocythemia: survey results from European hematologists/oncologists |
Q36269952 | Current update on reduced intensity regimens for allogeneic stem cell transplantation |
Q46226742 | Cyclin D1 expression in acute leukemia |
Q53543241 | Cyclin Dl expression in B-cell non Hodgkin lymphoma. |
Q44537232 | Cytochemical, immunophenotypic and ultrastructural characterization of acute leukemias: a prospective study of fifty cases: haematological malignancy |
Q37888830 | Cytogenetic abnormalities in myelodysplastic syndrome: an overview |
Q94450638 | Cytogenetic abnormalities in patients with newly diagnosed multiple myeloma as a secondary primary malignancy: a retrospective study |
Q39025570 | Cytogenetic profile of a large cohort of Tunisian de novo acute myeloid leukemia |
Q81409268 | Cytogenetic profile of acute lymphocytic leukemia patients: report of a novel translocation t(4;13) (q21 x 3; q35) from an Indian population |
Q38896511 | Cytokine Dysregulation in Acute Graft-versus-Host Disease |
Q53666438 | Cytokine profiles in stem cell transplantation: possible use as a predictor of graft-versus-host disease. |
Q40610275 | Cytokines and Cytomegalovirus Disease Following Allogeneic Bone Marrow Transplantation |
Q87901913 | Cytokines in Platelet Concentrates |
Q35552533 | Cytokines in sickle cell disease |
Q33367711 | Cytomegalovirus-induced thrombocytopenia in an immunocompetent adult effectively treated with intravenous immunoglobulin: a case report and review |
Q39286256 | Cytotoxic effect of arsenic trioxide on acute promyelocytic leukemia cells through suppression of NFkβ-dependent induction of hTERT due to down-regulation of Pin1 transcription |
Q86820967 | D-index dose not predict the development of pulmonary infection in acute myeloid leukemia patients undergoing consolidation chemotherapy with high-dose cytarabine |
Q81271201 | DLI: where are we know? |
Q34581359 | DNA microarray analysis: principles and clinical impact |
Q28255746 | DNA repair genes polymorphisms in multiple myeloma: no association with XRCC1 (Arg399Gln) polymorphism, but the XRCC4 (VNTR in intron 3 and G-1394T) and XPD (Lys751Gln) polymorphisms is associated with the disease in Turkish patients |
Q50055097 | Danazol increases T regulatory cells in patients with aplastic anemia. |
Q83649610 | Danazol therapy combined with intermittent application of chemotherapy induces lasting remission in myeloproliferative disorder (MPD): an alternative for the elderly with advanced MPD |
Q84974303 | Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R) CHOP |
Q44440137 | Decreased Transfusion Requirements in Patients Given Stem Cell Allografts Using a Non-myeloablative Conditioning Regimen: A Single Institution Experience |
Q104615188 | Decreased bone marrow regulatory innate lymphoid cells show a distinctive miRNA profiling in aplastic anemia |
Q85657330 | Decreased dickkopf-1 levels in chronic lymphocytic leukemia and increased osteopontin levels in non-Hodgkin's lymphoma at initial diagnosis: Could they be playing roles in pathogenesis? |
Q40062807 | Decreased levels of Th17 cells are associated with invasion fungal infections after allogeneic hematopoietic stem cell transplantation |
Q41578421 | Deep molecular responses achieved in chronic myeloid leukemia in chronic phase patients with BCR-ABL1 >10% at 3 months who are early switched to nilotinib |
Q88099141 | Deep vein thrombosis |
Q83304131 | Deficiency of CD3gamma, delta, epsilon, and zeta expression in T cells from AML patients |
Q35127001 | Dendritic cell-based immunotherapy for the treatment of hematological malignancies |
Q37293529 | Dengue virus related hemophagocytosis: a rare case report |
Q91145591 | Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis |
Q38880958 | Deregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromes |
Q47684162 | Detection and Identification of Single Molecules in Immunology and Immunohematology: Single (solution)-phase Single-molecule FCS. |
Q44765944 | Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib. |
Q45393748 | Detection of Epstein-Barr virus in children and adolescents with Burkitt's lymphoma by in situ hybridization using tissue microarrays |
Q73093751 | Detection of erythrocytes deficient in glycosylphosphatidyl-inositol anchored membrane proteins in patients with paroxysmal nocturnal hemoglobinuria by the toxin HEC secreted by Aeromonas hydrophila J-1 |
Q82653393 | Determination of donor-derived killer immunoglobulin-like receptor (KIR) by sequential genotyping in hematopoietic stem cell-transplanted patients |
Q54532003 | Development of Dermatomyositis in a Patient with Primary Myelofibrosis. |
Q84957605 | Diabetes mellitus is associated with high early-mortality and poor prognosis in patients with autoimmune hemolytic anemia |
Q84991918 | Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: results of a prospective long-term follow-up |
Q92468697 | Diagnosis and treatment of juvenile myelomonocytic leukemia |
Q38808158 | Diagnosis of factor XIII deficiency |
Q46490985 | Diagnosis of multiple myeloma using enzyme immunoassay for detection of antibodies to N-acetyl glucosamine on microparticles |
Q30239758 | Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran. |
Q64914983 | Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base. |
Q81271152 | Diagnostic approaches to bleeding disorders |
Q58596822 | Diagnostic utility of the lymphoid screening tube supplemented with CD34 for Ogata score calculation in patients with peripheral cytopenia |
Q102064422 | Diagnostic, prognostic and predictive values of miR-100 and miR-210 in pediatric acute lymphoblastic Leukemia |
Q79839446 | Diamond-Blackfan anemia: clinical features and treatment results in 4 cases |
Q100951755 | Diaphragm ultrasonography in adults with sickle cell anemia: evaluation of morphological and functional aspects |
Q82653407 | Diet and iron deficiency in the first year of life: a retrospective study |
Q47642100 | Differences in outcome for consecutive patients with diffuse large B-cell lymphoma before and after the advent of rituximab: a single-center experience. |
Q91817255 | Differences in pulmonary and extra-pulmonary characteristics in severely versus non-severely fatigued recipients of allogeneic hematopoietic stem cell transplantation: a cross-sectional, comparative study |
Q40835352 | Different Mechanisms of Resistance to Lymphokine-activated Killer (LAK) Cells in Leukemic Cell Sublines Selected by Etoposide or by LAK Cells. |
Q91128117 | Differentially expressed plasma proteins of β-thalassemia/hemoglobin E patients in response to curcuminoids/vitamin E antioxidant cocktails |
Q43905145 | Diffuse large B-cell lymphoma primary of lung. |
Q92959167 | Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer |
Q93253518 | Disappearance of monosomy 7 in a patient with aplastic anemia after eltrombopag treatment |
Q91628698 | Disordered bone metabolism in hereditary spherocytosis patients |
Q45055513 | Distribution of alpha-thalassemia mutations in Iranian population. |
Q92949398 | Distribution of sickle cell disease and assessment of risk factors based on transcranial Doppler values in the Gulf region |
Q36221531 | Divalent metal transporter 1. |
Q38899401 | Do SLCO1B3 (T334G) and CYP3A5*3 polymorphisms affect response in Egyptian chronic myeloid leukemia patients receiving imatinib therapy? |
Q46600561 | Do alpha deletions influence hydroxyurea response in thalassemia intermedia? |
Q39843822 | Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells |
Q51759891 | Does mobilization for autologous stem cell transplantation damage stromal layer formation? |
Q41717778 | Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis? |
Q92449544 | Donor CMV-specific cytotoxic T lymphocytes successfully treated drug-resistant cytomegalovirus encephalitis after allogeneic hematopoietic stem cell transplantation |
Q83903760 | Donor cell leukemia |
Q47606016 | Donor hematopoietic cells from transgenic mice that express GFP are immunogenic in immunocompetent recipients. |
Q47327078 | Dose dependent long-term in vivo remission of AML1/ETO positive acute myeloid leukemia with G-CSF. |
Q47195077 | Double vs. single cord blood transplantation in adolescent and adult hematological malignancies with heavier body weight (≥50 kg). |
Q33960952 | Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA. |
Q39477519 | Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance |
Q57462914 | Dr. S. Mitchell Lewis 1924-2018 |
Q36868609 | Duffy blood group and malaria |
Q58596834 | Dysfunction of immune system in the development of large granular lymphocyte leukemia |
Q49616958 | Dyspareunia is associated with chronic pain in premenopausal women with sickle cell disease. |
Q53630999 | Dysregulation of the NLRP3 inflammasome complex and related cytokines in patients with multiple myeloma. |
Q43926355 | EPAS1 p.M535T mutation in a Bulgarian family with congenital erythrocytosis |
Q36892389 | ESR or CRP? A comparison of their clinical utility |
Q86508090 | EUTOS CML prognostic scoring system predicts ELN-based 'event-free survival' better than Euro/Hasford and Sokal systems in CML patients receiving front-line imatinib mesylate |
Q82784917 | Early cytomegalovirus infections following allogeneic stem cell transplantation: a comparison between non-malignant and malignant haematological disorders |
Q59245121 | Early infections in patients undergoing high-dose treatment with stem cell support: a comparison of patients with non-Hodgkin lymphoma and multiple myeloma |
Q53568897 | Early lymphocyte recovery following autologous peripheral stem cell transplantation is associated with better survival in younger patients with lymphoproliferative disorders. |
Q40794987 | Early mortality in multiple myeloma: Experiences from a single institution |
Q91582996 | Economic burden of hemophilia A and B: a case in Iran |
Q83903838 | Economic evaluation of hematopoietic stem cell transplantation |
Q95461849 | Editorial |
Q95464393 | Editorial |
Q47624362 | Editorial Comment: Heterogeneity of Bone Marrow Stromal Cells Editorial Comment on Dr. Waller's Paper |
Q87912919 | Editorial on "Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective", Cheryl Hardy |
Q47618443 | Editorial on "Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective", Cheryl Hardy. |
Q53160078 | Editorial. Hematology as the official journal of the International Society of Hematology. |
Q83304127 | Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells |
Q87879336 | Effect of GM-CSF, 1, 25-Dihydroxycholecalciferol (Vit.D) and All-Trans-Retinoic Acid (ATRA) on the Proliferation and Differentiation of MDS-Bone Marrow (BM)-Cells In Vitro |
Q33386715 | Effect of Helicobacter pylori eradication on platelet count in children with chronic idiopathic thrombocytopenic purpura |
Q87910577 | Effect of Interferon-α on Patients with Previously Untreated Chronic Myelogenous Leukemia in the Early Chronic Phase: Comparison between Interferon-α Continued Patients and Interferon-α Discontinued Patients |
Q61942748 | Effect of Interleukin-1 α and Interleukin-1 β on Erythroid Progenitor Cell Growth in Serum Free Cultures: An In Vitro Study Relevant to the Pathogenesis of the Anemia of Chronic Disease |
Q45918792 | Effect of LMO2 protein expression on survival in chronic myeloid leukemia patients treated with imatinib mesylate. |
Q50692102 | Effect of gamma irradiation on blood from glucose 6 phosphate dehydrogenase deficient blood donors. |
Q42878309 | Effect of general and epidural anesthesia on hemostasis and fibrinolysis in hepatic patients. |
Q33401131 | Effect of glucose-6-phosphate dehydrogenase deficiency on some biophysical properties of human erythrocytes |
Q91987919 | Effect of iron chelation therapy on EPO-STAT5 signalling pathway and EPO resistance in iron-overloaded low-risk myelodysplastic syndrome patients |
Q33401584 | Effect of splenectomy on platelets associated antibodies in hepatitis C patients with thrombocytopenia |
Q46181753 | Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning |
Q48118195 | Effect of transfusion on cerebral oxygenation, flow velocity in a patient with sickle cell anemia and Moyamoya disease: a case report |
Q45985680 | Effect of vitamin C, deferoxamine, quercetin and rutin against tert-butyl hydroperoxide oxidative damage in human erythrocytes. |
Q50985408 | Effect of zinc supplementation on serum antibody titers to heat shock protein 27 in patients with thalassemia major. |
Q51009847 | Effect on haematological and anthropometric parameters of iron supplementation in the first 2 years of life. Risks and benefits. |
Q83649640 | Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients |
Q40441775 | Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma |
Q35104606 | Effectiveness of targeted therapy as monotherapy or combined therapy in patients with relapsed or refractory multiple myeloma: a systematic review and meta-analysis |
Q45931931 | Effects of aGVHD and cGVHD according to relapse status on survival rate in patients with acute lymphocytic leukemia. |
Q50711119 | Effects of hydroxyurea and L-arginine on the production of nitric oxide metabolites in cultures of normal and sickle erythrocytes. |
Q90049083 | Effects of ibrutinib on in vitro platelet aggregation in blood samples from healthy donors and donors with platelet dysfunction |
Q89066665 | Effects of nitric oxide donor S-nitrosoglutathione on apoptosis of apheresis platelets |
Q33385549 | Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura |
Q33391987 | Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia |
Q93385650 | Efficacy and safety of bispecific T-cell engager (BiTE) antibody blinatumomab for the treatment of relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin's lymphoma: a systemic review and meta-analysis |
Q41705410 | Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study. |
Q104567126 | Efficacy and safety of eltrombopag in the treatment of Chinese children with chronic immune thrombocytopenia |
Q104470376 | Efficacy and safety of four-factor prothrombin complex concentrate fixed, weight-based dosing for reversal of warfarin anticoagulation |
Q33375988 | Efficacy and safety of intravenous anti-D immunoglobulin (Rhophylac) in chronic immune thrombocytopenic purpura |
Q90203934 | Efficacy and safety of iron chelator for transfusion-dependent patients with myelodysplastic syndrome: a meta-analysis |
Q90463132 | Efficacy and safety of second-line treatment in Thai patients with primary warm-type autoimmune hemolytic anemia |
Q90911404 | Efficacy and tolerability of rituximab and reduced-dose cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy for elderly patient with diffuse large B-cell lymphoma |
Q92424234 | Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis |
Q47654837 | EgoNet identifies differential ego-modules and pathways related to prednisolone resistance in childhood acute lymphoblastic leukemia |
Q33413850 | Elevated levels of T-cell immune response cDNA 7 in patients with immune thrombocytopenia |
Q48097217 | Elevated plasma asymmetric dimethylarginine levels in children with beta-thalassemia major may be an early marker for endothelial dysfunction. |
Q46779569 | Elevated platelet microparticle levels in valvular atrial fibrillation |
Q53467101 | Elevated serum endostatin levels are associated with favorable outcome in acute myeloid leukemia. |
Q50724520 | Elevation of CD16+CD56+ NK-cells and down-regulation of serum interleukin-21 (IL-21) and IL-1α after splenectomy in relapsed hemophagocytic lymphohistiocytosis of unknown cause. |
Q74627666 | Elevation of serum KL-6 levels in patients with hematological malignancies associated with cytomegalovirus or Pneumocystis carinii pneumonia |
Q58131560 | Eliezer Rachmilewitz (1935-2017) |
Q48305083 | Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting. |
Q99353696 | Eltrombopag, oral immunosuppressant and androgen combination therapy in twelve patients with refractory severe aplastic anemia |
Q46374577 | Endocrine effects of erythropoietin in cancer patients |
Q87879608 | Endogenous Erythropoietin, Tumor Necrosis Factor-α and Interleukin-6 Levels after Peripheral Blood Stem Cell Transplantation |
Q46687489 | Endothelial nitric oxide synthase gene polymorphisms and the risk of vasculopathy in sickle cell disease |
Q87879056 | Enhanced Erythropoietin Response to Acute Hypoxemia in Mice with Pharmacological Depression of Erythropoiesis |
Q44765614 | Enhanced neutrophil apoptosis in neutropenic patients with hepatosplenic schistosomiasis: evidence of serum Fas ligand |
Q39710209 | Enhancement of specific cellular immune response induced by DNA vaccines encoding PML-RARalpha and hIL-2 genes |
Q36328391 | Enhancing siRNA effects in T cells for adoptive immunotherapy |
Q34234557 | Ensuring maximum outcomes and benefits in comprehensive care for bleeding disorders through surveillance and data collection |
Q40113207 | Epidemiologic study of major complications in adolescent and adult patients with thalassemia in Northeastern Thailand: the E-SAAN study phase I. |
Q38896595 | Epidemiology of Multiple Myeloma |
Q92449930 | Epidemiology of aplastic anemia: a study of 1324 cases |
Q43689745 | Epstein-Barr virus infections after allogeneic stem cell transplantation: a comparison between non-malignant and malignant hematological disorders |
Q59357918 | Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center |
Q40559190 | Eradication of Invasive Mucormycosis--Effectiveness of the Echinocandin FK463 |
Q87852864 | Erratum |
Q95439524 | Erratum |
Q34875235 | Erythroblast iron metabolism in sideroblastic and sideropenic states |
Q81243522 | Erythrocyte CD38 as a prognostic marker in cancer |
Q54586615 | Erythrocyte Deformability is Reduced and Fragility increased by Iron Deficiency. |
Q42952353 | Erythrocyte membrane defects and asymmetry in paroxysmal nocturnal hemoglobinuria and myelodysplastic syndrome |
Q50505304 | Erythrocyte membrane protein defects in hereditary spherocytosis patients in Turkish population. |
Q74000653 | Erythrocytes: Anemias in Chronic Liver Diseases |
Q42651785 | Erythrocytes: Better Tolerance of Iron Polymaltose Complex Compared with Ferrous Sulphate in the Treatment of Anaemia |
Q50477058 | Erythrocytic phosphatidylserine exposure and hemostatic alterations in β-thalassemia intermediate patients. |
Q74000532 | Erythropoiesis: Case Report: Congenital Dyserythropoietic Anemia Type II in a Woman Presenting with Jaundice, Anemia, and Splenomegaly |
Q74000437 | Erythropoiesis: Comparison of Cytotoxic Aldehyde Generation in Beta-Thalassemia Patients Chelated with Deferoxamine or Deferiprone (L1) Versus NO Chelation |
Q74000630 | Erythropoiesis: Correlations Between Iron Status Markers During Normal Pregnancy in Women with and without Iron Supplementation |
Q34278265 | Erythropoiesis: Current Clinical Practice: Advances in the Genetics and Biology of Fanconi Anaemia |
Q46233196 | Erythropoiesis: Erythrocyte Deformability is Reduced and Fragility increased by Iron Deficiency |
Q30654000 | Erythropoiesis: Hereditary Spherocytosis in Greece: Collective Data on a Large Number of Patients |
Q28201102 | Erythropoiesis: Paroxysmal Cold Haemoglobinuria: A Clinico-Pathological Study of Patients with a Positive Donath-Landsteiner Test |
Q74000441 | Erythropoiesis: Pyruvate Kinase Deficiency which Causes Nonspherocytic Hemolytic Anemia: The Gene and its Mutations |
Q34278250 | Erythropoiesis: Review Article: Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of beta-Thalassemia and Sickle Cell Disease. |
Q74000465 | Erythropoiesis: Short Report: Translation of Analysis Results between Serum Ferritin Assays, Ferritin RIA AmershamTM and Abbott AxSYMTM Ferritin |
Q30662837 | Erythropoiesis: Splenic Immunoglobulin Variable Region Genes Encoding Red Blood Cell Binding Fab Fragments in Autoimmune Hemolytic Anemia |
Q38690833 | Erythropoietin in anemia of unknown etiology: A systematic review and meta-analysis |
Q86829788 | Essential thrombocythaemia |
Q35022117 | Essential thrombocythemia (ET): moving from palliation to cure |
Q34875212 | Essential thrombocythemia: diagnosis and treatment, with special emphasis on the use of anagrelide |
Q54156955 | Estimated Blood Loss in Group O as Compared to Non-group O Radical Prostatectomy Patients. |
Q30244579 | Estimation of iron deficiency anemia in Iranian children and adolescents: a systematic review and meta-analysis. |
Q87896127 | Estimation of the Infectious Risks of Blood Transfusion |
Q47651447 | Estrogen receptor beta expression and prognosis of diffuse large B cell lymphoma. |
Q122998475 | Ethnic differences in acute promyelocytic leukaemia between New Zealand Polynesian and European patients |
Q92484137 | Etiology and clinico-hematological profile of pancytopenia: experience of a Mexican Tertiary Care Center and review of the literature |
Q36270040 | Etiopathogenesis of pediatric thrombosis |
Q101161627 | Etoposide combined with ruxolitinib for refractory hemophagocytic lymphohistiocytosis during pregnancy: a case report and literature review |
Q54565302 | European Concerted Action on Anticoagulation (ECAA): Clinical and Laboratory Studies. |
Q35197156 | Evaluating the effectiveness of epoetin alfa in community oncology practices |
Q53617967 | Evaluation of IGK and IGL molecular gene rearrangements according to the BIOMED-2 protocols for clinical diagnosis of Hodgkin lymphoma. |
Q46321468 | Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance |
Q80677021 | Evaluation of TCR Vbeta subfamily T cell expansion in NOD/SCID mice transplanted with human cord blood hematopoietic stem cells |
Q84753707 | Evaluation of an immunoturbidimetric D-dimer assay and pretest probability score for suspected venous thromboembolism in a district hospital setting |
Q38855963 | Evaluation of bone mineral density in children with hemophilia: Mansoura University children hospital (MUCH) experience, Mansoura, Egypt |
Q36285290 | Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging |
Q82653369 | Evaluation of factors associated with recruitment in hematological clinical trials: a retrospective cohort study |
Q45298325 | Evaluation of growth parameters in patients with thalassemia major |
Q88070196 | Evaluation of hypercoagulability with rotational thromboelastometry in children with iron deficiency anemia |
Q47666649 | Evaluation of multidrug resistance in 46 newly diagnosed patients with acute leukemia |
Q87343843 | Evaluation of neopterin as a biomarker for the monitoring of Gaucher disease patients |
Q36328397 | Evaluation of pulmonary infiltrates in patients after stem cell transplantation |
Q53791893 | Evaluation of serum and urine fetuin-A levels in children with acute lymphoblastic leukemia during and after high-dose methotrexate therapy: Relation to toxicity. |
Q42208353 | Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients. |
Q44310694 | Evaluation of umbilical cord blood CD34 (+) hematopoietic stem cell expansion in co-culture with bone marrow mesenchymal stem cells in the presence of TEPA. |
Q33382284 | Evans syndrome: a study of six cases with review of literature |
Q36276288 | Evolving molecular therapy for chronic myeloid leukaemia--are we on target? |
Q36892384 | Exertional rhabdomyolysis and renal failure in patients with sickle cell trait: is it time to change our approach? |
Q51688921 | Existence of cord compression in extramedullary hematopoiesis due to beta thalassemia intermedia. |
Q40835347 | Exogenous PML/RARα Fusion Gene Responds to All-trans Retinoic Acid Results in Differentiation of the Human B Cell Line |
Q53240284 | Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency. |
Q89264404 | Expression analysis of Akirin-2, NFκB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia |
Q93006968 | Expression and CpG island methylation pattern of MMP-2 and MMP-9 genes in patients with congenital factor XIII deficiency and intracranial hemorrhage |
Q96948152 | Expression and clinical significance of phospholipase D1 in de novo acute myeloid leukemia |
Q44009000 | Expression and prognostic value of FAS receptor/FAS ligand and TrailR1/TrailR2 in acute myeloid leukemia |
Q54244119 | Expression and promoter methylation changes of the P15INK4b during ex vivo cord blood CD34+ cell expansion following co-culture with mesenchymal stromal cells. |
Q48233285 | Expression and role of granulocyte macrophage colony-stimulating factor receptor (GM-CSFR) and granulocyte colony-stimulating factor receptor (G-CSFR) on Ph-positive acute B lymphoblastic leukemia. |
Q34278892 | Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia |
Q92492517 | Expression of BTK/p-BTK is different between CD5+ and CD5- B lymphocytes from Autoimmune Hemolytic Anemia/Evans syndromes |
Q33424522 | Expression of CD154 (CD40L) on stimulated T lymphocytes in patients with idopathic thrombocytopenic purpura. |
Q39296772 | Expression of CD56 is a risk factor for acute lymphocytic leukemia with central nervous system involvement in adults |
Q45856281 | Expression of Factor IX cDNA Introduced into Human Marrow Stromal Cells by Electroporation. |
Q44964318 | Expression of P16 cell cycle inhibitor in human cord blood CD34+ expanded cells following co-culture with bone marrow-derived mesenchymal stem cells |
Q54442929 | Expression of WT1 gene in multiple myeloma patients at diagnosis: is WT1 gene expression a useful marker in multiple myeloma? |
Q79964224 | Expression of apoptosis regulators Bcl-2 and Bax in childhood acute lymphoblastic leukemia |
Q87597955 | Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia |
Q79964216 | Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias |
Q90175412 | Expression of serum BMP6 and hepcidin in cancer-related anemia |
Q46551442 | Expression of thioredoxin-1 (TXN) and its relation with oxidative DNA damage and treatment outcome in adult AML and ALL: A comparative study |
Q38763444 | Expression of vaccinia-related kinase 1 (VRK1) accelerates cell proliferation but overcomes cell adhesion mediated drug resistance (CAM-DR) in multiple myeloma |
Q50228191 | Expression pattern of CD55 and CD59 on red blood cells in sickle cell disease. |
Q81271211 | External quality assessment scheme by private laboratories in Turkey |
Q41450891 | Extracellular accumulation of bioactive substances; interleukin-1beta (IL-1beta) and plasminogen activator inhibitor-1 (PAI-1) in stored blood units and relation to bacterial contamination |
Q114098159 | Extracorporeal photopheresis for the treatment of chronic graft versus host disease |
Q81783314 | Extranodal lymphoma: a comparative study |
Q87911034 | Extreme Thrombocytosis after Penetrating Femoral Venous Injury |
Q48299475 | FC gamma receptor polymorphisms in patients with immune thrombocytopenia. |
Q63440154 | Facilities for the treatment of adults with haematological malignancies – 'Levels of Care': BCSH Haemato-Oncology Task Force 2009 |
Q39447734 | Factor V Leiden and prothrombin gene mutations in Egyptian cases with unexplained recurrent pregnancy loss |
Q53655617 | Factor V Leiden detection by polymerase chain reaction-restriction fragment length polymorphism with mutagenic primers in a multiplex reaction with Pro G20210A--a novel technique. |
Q91326508 | Factor VII deficiency - an enigma; clinicohematological profile in 12 cases |
Q33394560 | Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin |
Q39103011 | Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes |
Q38855960 | Failure of puberty in Egyptian beta thalassemic patients: experience in north east region - Dakahlia province |
Q87903094 | Familial Myelodysplastic Syndrome/Acute Myeloid Leukaemia With Monosomy 7: Report of a New Kindred |
Q36269999 | Fanconi anemia: current management |
Q41378115 | Fasudil, a clinically safe ROCK inhibitor, decreases disease burden in a Cbl/Cbl-b deficiency-driven murine model of myeloproliferative disorders |
Q57518582 | Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia |
Q33433926 | Fatal Pancreatic Necrosis after Pregnancy-Associated Thrombotic Thrombocytopenic Purpura |
Q33365360 | Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy |
Q51817075 | Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3-CD19 depletion. |
Q45848074 | Features and clinical outcomes in 40 patients with mixed-lineage acute leukemia in a single center |
Q36270114 | Febrile neutropenia--seven frequently asked questions and answers |
Q40210717 | Febrile neutropenia: median door-to-needle time - results of an initial audit |
Q87910588 | Fetal Erythropoiesis after Allogeneic Bone Marrow Transplantation Estimated by the Peripheral Blood Erythrocytes Containing Hemoglobin F (F-cells) |
Q87903097 | Fibrin Glue for Bleeding Peptic Ulcers |
Q39939244 | Fibronectin promotes cell proliferation of human pre-B cell line via its interactions with VLA-4 and VLA-5. |
Q91683308 | Ficolled bone marrow is superior to bone marrow buffy coat for detection of minimal residual disease in multiple myeloma |
Q81243475 | First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers |
Q81409276 | First report of a nonsense mutation at codon 15(TGG-->TAG) in exon 1 of the beta globin gene in a beta thalassemia trait in State of Orissa, India |
Q54542083 | First reported case of prenatal diagnosis for pyruvate kinase deficiency in a Chinese family. |
Q86065324 | Fish consumption and risk of non-Hodgkin lymphoma: A meta-analysis of observational studies |
Q81243531 | Fixed dose prothrombin complex concentrate for the reversal of oral anticoagulation therapy |
Q47885241 | Flow cytometric analysis of patients with hereditary spherocytosis - an Indian scenario |
Q53036476 | Flow cytometric assessment of endothelial and platelet microparticles in preeclampsia and their relation to disease severity and Doppler parameters. |
Q44096697 | Flow cytometric comparison of platelets from a whole blood and finger-prick sample: impact of 24 hours storage |
Q35809442 | Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes |
Q87879792 | Fluorescence In Situ Hybridization: Trisomy 12 Follow-up In Hairy Cell Leukemia |
Q83504858 | Fluorescent in situ hybridization studies in multiple myeloma |
Q83304162 | Fok-I gene polymorphism of vitamin D receptor in patients with beta-thalassemia major and its effect on vitamin D status |
Q33367708 | Fondaparinux: a potential new therapy for HIT. |
Q45856357 | Fractionation of Gene Modified Hematopoietic Autografts into Multiple Weekly Infusions Does Not Improve Engraftment in Unconditioned Canine Recipients |
Q84957604 | Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemia |
Q39447770 | Frequency of factor V Leiden mutation in Egyptian cases with myocardial infarction. |
Q91628691 | Frequency of iron deficiency anemia in pregnant and non-pregnant women suffering from restless legs syndrome |
Q54306982 | Frequency of thrombophilic genetic polymorphisms among Saudi subjects compared with other populations. |
Q59423170 | Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome–positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up |
Q58050726 | Frontline treatment of multiple myeloma |
Q38731027 | Fusion genes in malignant neoplastic disorders of haematopoietic system |
Q87876109 | G CSF: A First Line Therapy for Autoimmune Neutropenia? |
Q74000725 | G-CSF Primed Autologous Marrow Harvest and Transplantation in Cytapheresis "Mobilization Failure" Patients: A Descriptive Analysis; Bone Marrow Transplantation |
Q87879803 | G-CSF Regulates the Expression of mRNA for Collagen Type VI and Collagen VI Production in Human Bone Marrow Stromal Cells |
Q86317992 | G-CSF induces up-regulation of CXCR4 expression in human hematopoietic stem cells by beta-adrenergic agonist |
Q50732902 | G6PD deficiency with hemolytic anemia due to a rare gene deletion--a report of the first case in Malaysia. |
Q80677026 | GATA-1, -2 and -3 genes expression in bone marrow microenviroment with chronic aplastic anemia |
Q40303868 | GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome. |
Q91384499 | GDF11 is increased in patients with aplastic anemia |
Q41240899 | GM-CSF Priming of U937 Monocytic Cells Accelerates, But Does Not Increase, Tissue Factor (TF) Expression or Procoagulant Activity (PCA) After Stimulation with Endotoxin (LPS). |
Q86429007 | GPRC5D is a promising marker for monitoring the tumor load and to target multiple myeloma cells |
Q40457696 | GSTT1 (rs4025935) null genotype is associated with increased risk of sickle cell disease in the populations of Tabuk-Northwestern region of Saudi Arabia. |
Q38556887 | Gamma heavy chain disease associated with large granular lymphocytic leukemia: A report of two cases and review of the literature. |
Q30244317 | Gaucher disease epidemiology and natural history: a comprehensive review of the literature. |
Q61868130 | Gemcitabine, cisplatin and methylprednisolone (GEM-P) with or without Rituximab in relapsed and refractory patients with diffuse large B cell lymphoma (DLBCL) |
Q36221521 | Gene expression profiling in the myelodysplastic syndromes |
Q84616301 | Gene expression profiling of CD3gamma, delta, epsilon, and zeta chains in CD4(+) and CD8(+) T cells from human umbilical cord blood |
Q35809458 | Generation of dendritic cells using cell culture bags--description of a method and review of literature |
Q53378105 | Generation of lymphocytes potentiated against leukemic lymphoblasts by stimulation using leukemic cell lysate-pulsed dendritic cells in patients with acute lymphoblastic leukemia and measurement of in vitro anti-leukemic cytotoxicity. |
Q50994599 | Genetic analysis of a hereditary factor XII deficiency pedigree of a consanguineous marriage due to a homozygous F12 gene mutation: Gly341Arg. |
Q37270864 | Genetic determinants of phenotype in beta-thalassemia. |
Q38938998 | Genetic link with cholelithiasis among pediatric SCA Tunisian patients: Examples of UGT1A1, SLCO1A2 and SLCO1B1. |
Q36799622 | Genetically heterogeneous origins of idiopathic erythrocytosis |
Q52594557 | Geographical distribution of β-globin gene mutations in Syria. |
Q48368346 | Gestational age and childhood leukemia: A meta-analysis of epidemiologic studies |
Q35552538 | Gfi-1 Oncoproteins in Hematopoiesis |
Q33368667 | Giant platelet syndrome |
Q51513959 | Gilbert's syndrome disclosed during the treatment of hematological malignancies. |
Q34380139 | Glucose-6-phosphate dehydrogenase Guadalajara--a case of chronic non-spherocytic haemolytic anaemia responding to splenectomy and the role of splenectomy in this disorder |
Q39260470 | Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major. |
Q39691616 | Gossypol exerts its cytotoxic effect on HL-60 leukemic cell line via decreasing activity of protein phosphatase 2A and interacting with human telomerase reverse transcriptase activity. |
Q50794130 | Graft-versus-host disease confined solely to intestine after allogeneic peripheral blood stem cells transplantation in a patient with chronic myelogenous leukemia. |
Q53751930 | Granulocyte-Colony Stimulating Factor (G-CSF) Administration for Chemotherapy-Induced Neutropenia. |
Q87879044 | Granulocyte-Macrophage Colony-Stimulating Factor in Newly Diagnosed Adult Patients with Acute Lymphoblastic Leukemia Treated with Conventional Chemotherapy |
Q35809463 | Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines. |
Q36307582 | Granulocytic adhesive interactions and their role in sickle cell vaso-occlusion |
Q36270065 | Gray zone lymphomas |
Q74000526 | Growth Factors: Production of Monocyte Chemotactic Protein-1 (MCP-1/JE) by Bone Marrow Stromal Cells: Effect on the Migration and Proliferation of Hematopoietic Progenitor Cells |
Q33337681 | Growth Factors: Thrombopoietic Property of the Pineal Hormone Melatonin |
Q38042777 | Guidelines on obtaining consent for systemic anti-cancer therapy in adults |
Q46599911 | HFE gene mutation and iron overload in Egyptian pediatric acute lymphoblastic leukemia survivors: a single-center study. |
Q38866780 | HLA class II polymorphism in Egyptian children with lymphomas |
Q51759881 | HLA-G expression in B chronic lymphocytic leukemia: a new prognostic marker? |
Q40428384 | HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin). |
Q38897817 | HTLV-1 and Adult T-Cell Leukemia/Lymphoma: A Review |
Q38894418 | Haematologic Malignancy Secondary to the Treatment of Lymphoma |
Q45863419 | Haematology clinic: Haemophilia A. |
Q51127214 | Haemoglobin F, A2, and S levels in subjects with or without sickle cell trait in south-eastern Gabon. |
Q85900169 | Haemolysis secondary to intravenous immunoglobulins for ITP |
Q36844901 | Haemopoietic stem cell transplantation--an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology |
Q74000596 | Haemostasis and Thrombosis: Current Clinical Practice: Current Management of Thrombotic Thrombocytopenic Purpura |
Q47208475 | Haemostasis and Thrombosis: Current Clinical Practice: Low-Molecular-Weight Heparins in The Prophylaxis and Treatment of Thrombo-Embolic Disease. |
Q47683898 | Haemostatic Abnormalities in Patients with a Clinical Predisposition to Venous Thromboembolism |
Q36269967 | Haemovigilance in developing countries |
Q84965336 | Halofugine prevents cutaneous graft versus host disease by suppression of Th17 differentiation |
Q87878043 | Handbook of Blood Transfusion Therapy, 2nd Edition |
Q100547453 | Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis |
Q41648349 | Haptoglobin genotypes polymorphism as a risk factor for subclinical atherosclerosis in beta-thalassemia major children; a single center Egyptian study |
Q87876114 | Has Lactoferrin a Role in Hereditary Hemochromatosis? |
Q50467588 | Hb A2 Episkopi - a novel δ-globin chain variant [HBD:c.428C>T] in a family of mixed Cypriot-Lebanese descent. |
Q50485384 | Hb Koln [β98(FG5) [GTG → ATG, Val → Met]: the first report from India. |
Q50459801 | HbF in HbE/β-thalassemia: A clinical and laboratory correlation. |
Q52381951 | Health-related quality of life before and after hematopoietic stem cell transplant: evidence from a survey in Suzhou, China. |
Q36194587 | Heat shock proteins and acute leukemias |
Q51691220 | Hematologic malignancies in the medical intensive care unit--Outcomes and prognostic factors. |
Q101125635 | Hematologic predictors of mortality in hospitalized patients with COVID-19: a comparative study |
Q40907380 | Hematological Effects of Chernobyl In Belarus: Do They Really Exist Ten Years Later? |
Q33375520 | Hematological presentation in systemic lupus erythematosus and its relationship with disease activity |
Q40407333 | Hematological profile in pyrexia of unknown origin: role of bone marrow trephine biopsy vis-à-vis aspiration. |
Q87938477 | Hematology clinic. Acute lymphoblastic leukemia |
Q45286978 | Hematology clinic: chronic myelogenous leukemia |
Q36270031 | Hematology education in a problem-based curriculum. |
Q47326165 | Hematology morphology forum |
Q73634897 | Hematology morphology forum |
Q74627676 | Hematology morphology forum |
Q80214608 | Hematology morphology forum |
Q73093757 | Hematology morphology forum case 1. Granulocytic sarcoma |
Q73390755 | Hematology morphology forum case 2. Mycobacterial spindle-cell pseudotumor of the lymph nodes |
Q73795188 | Hematology morphology forum case 3. Chediak-Higashi syndrome |
Q43880098 | Hematology morphology forum. Clostridium welchii septicemia. |
Q45204117 | Hematology morphology forum. Paroxysmal cold haemoglobinuria |
Q83903694 | Hematology. Editorial |
Q81271235 | Hematomorphology |
Q35809433 | Hematopoiesis in the elderly. |
Q74000673 | Hematopoiesis: Gap Junction Intercellular Communication is Likely to be Involved in Regulation of Stroma-dependent Proliferation of Hemopoietic Stem Cells |
Q40799505 | Hematopoiesis: The Role of Stromal Integrin Interactions in Pro-B Cell Proliferation |
Q40907374 | Hematopoietic Growth Factors and Blast Progenitors in Acute Leukemia |
Q54515818 | Hematopoietic cell transplantation for chronic myeloid leukemia in developing countries: perspectives from Latin America in the post-tyrosine kinase inhibitor era. |
Q46820835 | Hematopoietic cell transplantation in Latin America |
Q36868596 | Hematopoietic changes during progression from Fanconi anemia into acute myeloid leukemia: case report and brief review of the literature |
Q83903832 | Hematopoietic stem cell transplantation in Europe. Differences between Eastern and Western countries |
Q40632418 | Hematopoietic stem cell transplantation: the Vancouver experience |
Q37854920 | Hematopoietic stromal cells and megakaryocyte development |
Q38848661 | Heme oxygenase-1 plays a crucial role in chemoresistance in acute myeloid leukemia |
Q40800759 | Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome. |
Q84429884 | Hemoglobin D-Punjab syndromes in India: a single center experience on cation-exchange high performance liquid chromatography |
Q80677033 | Hemoglobin E disease in North Indian population: a report of 11 cases |
Q87910600 | Hemophagocytic Syndrome Induced by HIV |
Q36269994 | Hemophagocytic lymphohistiocytosis |
Q38061236 | Hemophagocytic lymphohistiocytosis in pregnancy: a case report and review of treatment options |
Q38749849 | Hemophilia in Iran. |
Q33337683 | Hemostasis and Thrombosis: Clinical Usefulness of Combined use of Platelet Aggregation Test and Anti PF4-H. Antibodies Elisa test for the Diagnosis of Heparin Induced Thrombocytopenia |
Q36746455 | Hemostatic changes in thyroid diseases: haemostasis and thrombosis |
Q87912104 | Heparin Induces Apoptosis in Lymphocytes from B-cell Chronic Lymphocytic Leukemia |
Q33371422 | Heparin cofactor II as a predictor of thrombotic microangiopathy after bone marrow transplantation |
Q33380753 | Heparin induced thrombocytopenia with thrombosis: a two step process? |
Q39293427 | Hepatitis B reactivation in patients receiving targeted therapies |
Q42952349 | Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies |
Q87876333 | Hepatosplenic Candidiasis, its Treatment and Effect on Remission Status in Patients with Acute Leukaemia-a Report of Five Cases |
Q36069473 | Hepcidin and cytokines in anaemia |
Q46965468 | Hepcidin expression from monocyte of splenectomized and non-splenectomized patients with HbE-β-thalassemia |
Q47684174 | Hereditary Red Cell Membrane Disorders in Japan: Their Genotypic and Phenotypic Features in 1014 Cases Studied |
Q47683800 | Hereditary Thrombophilic Disease Associated with Defects in the Protein C Anticoagulant System |
Q36416003 | Hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency: a biochemical, genetic and clinical overview. |
Q80376751 | Hereditary hemochromatosis |
Q86536383 | Hereditary hemochromatosis |
Q102203771 | Hereditary spherocytosis overlooked for 7 years in a pediatric patient with β-thalassemia trait and novel compound heterozygous mutations of SPTA1 gene |
Q87910585 | Herpesvirus Infection in Patients Following Bone Marrow Transplantation: Influence of Viral Reactivation on Prognosis |
Q33410603 | Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation. |
Q33433886 | High Dose Chemotherapy in the Treatment of Poor Prognosis Malignant Lymphoma |
Q48347302 | High absolute basophil count is a powerful independent predictor of inferior overall survival in patients with primary myelofibrosis |
Q40559541 | High expression of Midkine (MK) indicates poor prognosis in childhood acute lymphoblastic leukemia |
Q45149702 | High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burden |
Q37107428 | High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for 'late effects' screening and preventive strategies. |
Q60339416 | High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma |
Q38866790 | Histiocytosis disorders in Northeast Egypt: epidemiology and survival studies (a 5-year study). |
Q73795176 | Hodgkin's disease variant of Richter's syndrome: complete remission of the both malignancies after 14 years |
Q84925674 | Homing and engraftment of bone marrow cells derived from different donors in a murine model of sensitization |
Q35994823 | Homoharringtonine: a new treatment option for myeloid leukemia |
Q48286519 | Homozygous FVII deficiencies with different reactivity towards tissue thromboplastins of different origin |
Q126265060 | Honokiol induces apoptosis and autophagy in dexamethasone-resistant T-acute lymphoblastic leukemia CEM-C1 cells |
Q36270130 | How can hematopoietic cell transplant centers and referring physicians help each other during long-term follow-up? |
Q33367294 | Human T-lymphotropic virus type I infection and idiopathic thrombocytopnic purpura |
Q53721867 | Human platelet antigen 1, 2 and 5 gene polymorphisms in Egyptians and their potential association with susceptibility to immune thrombocytopenic purpura in Egyptian patients. |
Q34879042 | Human umbilical cord blood-derived stromal cells: a new resource for the proliferation and apoptosis of myeloma cells |
Q54242690 | Humoral immune response of childhood acute lymphoblastic leukemia survivors against the measles, mumps, and rubella vaccination. |
Q61913883 | Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron |
Q51742765 | Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports. |
Q87901911 | Hydroxyurea is Worth a Trial in the Treatment of Patients with MDS with Myeloproliferative Features |
Q74000754 | Hypercalcemia after High-Dose Chemoradiotherapy for Refractory Multiple Myeloma; Subject Heading |
Q38897888 | Hypereosinophilia Progressing to Granulocytic Sarcoma and Acute Myelocytic Leukemia with Trisomy 8: A Case Report and Review of the Literature |
Q59358534 | Hyperferritinemia: causes and significance in a general hospital |
Q50794125 | Hyperhaemolysis syndrome in a patient with myelofibrosis. |
Q104470386 | Hyperleukocytosis predicts inferior clinical outcome in pediatric acute myeloid leukemia |
Q36761720 | Hyposplenism: a comprehensive review. Part I: basic concepts and causes |
Q36799619 | Hyposplenism: a comprehensive review. Part II: clinical manifestations, diagnosis, and management |
Q41083935 | IL-10-592 A/C polymorphisms is associated with EBV-HLH in Chinese children |
Q41073890 | IL1α and TNFα Induction of Monocyte Chemoattractant Protein-1 (MCP-1/JE) in Bone Marrow Stromal Cells: The Role of Protein Kinase C (PKC) and Protein Tyrosine Kinase (PTK) Activity |
Q53710223 | ISH 2014 World Congress: report of the Chair of Council. |
Q88165725 | ISH Newsletter |
Q91628679 | ISH Newsletter |
Q87173901 | ISH initiatives for global hematology education and potential opportunities for sponsorships |
Q50244445 | Identification and molecular characterization of a novel 163 kb deletion: The Italian (ϵγδβ)(0)-thalassemia. |
Q47327031 | Identification of Hb Q-India (alpha64 Asp-->His) in Thailand |
Q53773523 | Identification of Patients with Storage Pool Deficiency Using ATP Release and Dense Granule Counts. |
Q47445409 | Identification of a de novo ANK1 mutation in a Chinese family with hereditary spherocytosis |
Q98285362 | Identification of latent core genes and pathways associated with myelodysplastic syndromes based on integrated bioinformatics analysis |
Q38342048 | Identification of new markers discriminating between myeloid and lymphoid acute leukemia |
Q93253523 | Identification of potential miRNA-mRNA interaction network in bone marrow T cells of acquired aplastic anemia |
Q38199534 | Identification of the potential risk factors for monoclonal gammopathy of undetermined significance of progression |
Q33430236 | Identifying the characteristics, natural behavioral pattern, and response to therapy in ITP in a multi-center population in Sri Lanka |
Q33380751 | Idiopathic thrombocytopenic purpura in childhood: a 10-year audit |
Q47683117 | Idiotypic Immune Targeting of Multiple Myeloma |
Q50676897 | IgA anti-red blood cell auto-antibodies in Evans syndrome. |
Q99205177 | IgG4 plasma cell myeloma without clinical evidence of IgG4-related disease: a report of two cases |
Q87911029 | IgM Myeloma: An IgM Gammopathy Distinct from Waldenstrom's Macroglobulinemia |
Q47683128 | Imaging Multidrug Resistance in Hematological Malignancies |
Q44440134 | Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias |
Q39573963 | Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells |
Q36761730 | Imatinib-induced immune hepatitis: case report and literature review |
Q33411812 | Immature platelet fraction levels in a variety of bone marrow pathologies in South African HIV-positive patients with thrombocytopenia |
Q33423312 | Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia. |
Q47581984 | Immune Reconstitution and Early Infectious Complications Following Nonmyeloablative Hematopoietic Stem Cell Transplantation |
Q35994828 | Immune agranulocytosis and clarithromycin |
Q50057993 | Immune dysregulation in primary immune thrombocytopenia patients. |
Q35080319 | Immune reconstitution and tolerance after allogeneic hematopoietic stem cell transplantation |
Q46364017 | Immune reconstitution during maintenance therapy in children with acute lymphoblastic leukemia, relation to co-existing infection |
Q87046416 | Immune thrombocytopenia |
Q35994817 | Immune tolerance therapy in patients with acquired hemophilia |
Q91964185 | Immunoglobulin D (IgD) and IgD receptor expression in diffuse large B-cell lymphoma |
Q82835014 | Immunoglobulin free light chains: do they have a role in plasma cell leukemia? |
Q34789270 | Immunohematological aspects of bone marrow transplantation |
Q85493871 | Immunohistological analysis in diagnosis of plasma cell myeloma based on cytoplasmic kappa/lambda ratio of CD38-positive plasma cells |
Q38640438 | Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD. |
Q36270148 | Immunotherapeutic aspects of stem cell transplantation |
Q46779190 | Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling |
Q41008753 | Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma |
Q51755925 | Impact of FLT3 internal tandem duplications on Indian acute promyelocytic leukemia patients: prognostic implications. |
Q43785416 | Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patients. |
Q95305436 | Impact of anemia on the outcomes of chronic phase chronic myeloid leukemia in TKI era |
Q57253038 | Impact of anti‐oxidant status and apoptosis on the induction phase of chemotherapy in childhood acute lymphoblastic leukemia |
Q36270126 | Impact of chronic GVHD on late complications after hematopoietic cell transplantation |
Q38858532 | Impact of educational programme regarding chelation therapy on the quality of life for B-thalassemia major children |
Q52747009 | Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation. |
Q46793590 | Impact of excess weight and estrogen receptor gene polymorphisms on clinical course of homozygous beta thalassemia |
Q89066560 | Impact of interleukin 6 promoter polymorphisms (-174 G > C, -572 G > C and -597 G > A) on plasma IL-6 levels and their influence on the development of DVT: a study from India |
Q36270049 | Impact of molecular profiling and cytogenetics in acute lymphoblastic leukemia |
Q40312709 | Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities |
Q44647000 | Impact of serum adiponectin and leptin levels in acute leukemia |
Q33435188 | Impact of serum immunoglobulins level and IL-18 promoter gene polymorphism among Egyptian patients with idiopathic thrombocytopenic purpura |
Q50599578 | Impact of socioeconomic status on sexual maturation of Nigerian boys living with sickle cell anaemia. |
Q42232106 | Impact of treatment-related toxicity on outcome of HCV-positive diffuse large B-cell lymphoma in rituximab era. |
Q51743060 | Impact on acute myeloid leukemia relapse in granulocyte colony-stimulating factor application: a meta-analysis. |
Q35080326 | Impaired phagocyte antibacterial effector functions in beta-thalassemia: a likely factor in the increased susceptibility to bacterial infections |
Q46753529 | Implication of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Interleukin-3 (IL-3) in Children with Acute Myeloid Leukaemia (AML). |
Q74000819 | Implication of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Interleukin-3 (IL-3) in Children with Acute Myeloid Leukaemia (AML); Malignancy |
Q93049928 | Improvement of the hematologic toxicities of ruxolitinib in patients with MPN-associated myelofibrosis using a combination of thalidomide, stanozolol and prednisone |
Q38003016 | Improving treatment for patients with chronic lymphocytic leukemia |
Q40628679 | In VitroCytotoxic Effects of Stabilizing Sugars within Human Intravenous Immunoglobulin Preparations against the Human Macrophage THP-1 Cell-line |
Q85899341 | In pursuit of the graft-versus-myeloma effect: a single institution experience |
Q36269975 | In search of the transfusion threshold |
Q83903826 | In vitro biology of human hematopoietic stem and progenitor cells |
Q54694441 | In vitro cell cycle dynamics of primitive hematopoietic cells from human umbilical cord blood. |
Q44941953 | In vitro evaluation of cytochrome P450-mediated drug interactions between cytarabine, idarubicin, itraconazole and caspofungin |
Q50146370 | Incidence of Fanconi anaemia in phenotypically normal aplastic anaemia patients in West Bengal. |
Q44864941 | Incidence of anemia and effect of nutritional supplementation on women in rural and tribal populations of eastern and northeastern India |
Q39676625 | Incidence of aplastic anemia in a defined subpopulation from Mexico City |
Q45891572 | Incidence of internal tandem duplications and D835 mutations of FLT3 gene in chronic myeloid leukemia patients from Southern India |
Q51730820 | Incidence, etiology and bone marrow characteristics of non-chemotherapy-induced agranulocytosis. |
Q46162832 | Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia |
Q95646498 | Increased circulating basic fibroblast growth factor levels in acute myeloid leukemia: a meta-analysis |
Q53122379 | Increased expression of HERG K+ channels contributes to myelodysplastic syndrome progression and displays correlation with prognosis stratification. |
Q53381589 | Increased expression of metalloproteinase-2 and -9 (MMP-2, MMP-9), tissue inhibitor of metalloproteinase-1 and -2 (TIMP-1, TIMP-2), and EMMPRIN (CD147) in multiple myeloma. |
Q38747439 | Increased regulatory T cells in acute lymphoblastic leukaemia patients |
Q38539663 | Increased regulatory T cells in acute lymphoblastic leukemia patients |
Q55042855 | Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation? |
Q44941744 | Increments in circulating homocysteine before and after coronary artery bypass surgery in diabetic and non-diabetic patients |
Q87878299 | Indications for and Value of Bone Marrow Trephine Biopsy in Haematological Disorders |
Q53122380 | Indoleamine 2,3-dioxygenase and regulatory T cells in acute myeloid leukemia. |
Q47684293 | Induction of Apoptosis in Human Leukaemia Cells is Differentially Regulated by Vitamin D Derivatives and Retinoids |
Q87879342 | Induction of Erythropoiesis by MHC-Mediated Cognate Interactions between B- and T-Cells |
Q80454253 | Ineffectiveness of oral iron hydroxide polymaltose in iron-deficiency anemia |
Q74816951 | Infectious mononucleosis, peripheral blood. Hematology morphology forum |
Q91315088 | Inflammation in deep vein thrombosis: a therapeutic target? |
Q39950750 | Influence of Epstein-Barr virus infection in adult T-cell leukemia |
Q83979163 | Influence of Helicobacter pylori infection associated with iron deficiency anaemia on growth in pre-adolescent children |
Q50482880 | Influence of age on the correlations of hematological and biochemical variables with the stability of erythrocyte membrane in relation to sodium dodecyl sulfate. |
Q35080323 | Influence of one human leukocyte antigen mismatch on outcome of allogeneic bone marrow transplantation from related donors |
Q46374569 | Influence of storage time and temperature on international normalized ratio (INR) levels and plasma activities of vitamin K dependent clotting factors |
Q74000712 | Infusional 5-fluorouracil in Cutaneous Leukaemia: a Novel Palliative Therapy in Haematological Malignancy; Malignancy |
Q38556035 | Inherited bone marrow failure syndromes |
Q36868584 | Inherited factor XI deficiency: a concise review |
Q33423706 | Inherited thrombocytopenias. |
Q83903810 | Inherited thrombophilic conditions |
Q43434378 | Inhibition of Stat3 expression induces apoptosis and suppresses proliferation in human leukemia HL-60 cells |
Q38722874 | Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells. |
Q90081304 | Inhibitor eradication and bleeding management of acquired hemophilia A: a single center experience in China |
Q46504842 | Innovative PCR without DNA extraction for African sickle cell disease diagnosis. |
Q87912385 | Insulin-like Growth Factor-1 (IGF-1) is a Costimulator of the Expansion of Lineage Committed Cells Derived from Peripheral Blood Mobilized CD34(+) Cells in Multiple Myeloma Patients |
Q38471219 | Integrating GO and KEGG terms to characterize and predict acute myeloid leukemia-related genes |
Q87878280 | Intensified Induction and Post-Remission Therapy for Acute Myeloid Leukaemia |
Q52552734 | Interaction between Hb E and Hb Yala (HBB:c.129delT); a novel frameshift beta globin gene mutation, resulting in Hemoglobin E/β0 thalassemia. |
Q92263772 | Interactions of unstable hemoglobin Rush with thalassemia and hemoglobin E result in thalassemia intermedia |
Q43632085 | Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma |
Q53245753 | Interferon-γ mediates the immunosuppression of bone marrow mesenchymal stem cells on T-lymphocytes in vitro. |
Q87912099 | Interleukin 4 (IL4), IL10 and IL13 Inhibit in vitro Cytokine Secretion by Acute Myelogenous Leukemia Blasts in the Presence of Exogenous Hematopoietic Growth Factors |
Q41073895 | Interleukin-11 Gene Expression in Human Lymphoid Malignancy |
Q87879048 | Interleukin-11: Its Characterization and Physiological Effects |
Q40874242 | Interleukin-3: Promises and Perspectives |
Q39337514 | Interleukin-8 in the pathogenesis of primary central nervous system lymphoma in association with HIV infection |
Q90590809 | International sentinel site surveillance of patients with transfusional hemosiderosis treated with deferasirox in actual practice setting |
Q42878314 | Interstitial insertion of RARα gene into PML gene in a patient with acute promyelocytic leukemia (APL) lacking the classic t(15;17). |
Q33374583 | Interstitial lung disease (ILD) and severe ITP. |
Q87911785 | Intestinal Iron Transport and its Regulation |
Q87911039 | Intraerythrocytic Iron Chelation: A New Therapy for Thalassemia? |
Q92453162 | Intrathecal dose intensification by CNS status at diagnosis in the treatment of children with acute lymphoblastic leukemia |
Q50749821 | Intravenous immunoglobulin given to lymphoma patients with recurrent haemolytic transfusion reactions after transfusion of compatible blood. |
Q46523649 | Introduction of new formulas and evaluation of the previous red blood cell indices and formulas in the differentiation between beta thalassemia trait and iron deficiency anemia in the Makkah region |
Q51465317 | Introduction of novel α1-hemoglobin gene mutation with transfusion-dependent phenotype. |
Q36270101 | Introduction--the global problem of nutritional anemias |
Q47622124 | Introductory Commentary on Gap Junction Intercellular Communication is Likely to be Involved in Regulation of Stroma-dependent Proliferation of Hematopoietic Stem Cells Ploemacher R. Et Al. |
Q47618479 | Introductory Commentary on Regulation of LFA-1 Expression by CD34+ Cells and Inducible Growth Factor Production by Stroma Enable Formation of Bone Marrow Compartments, Torensma et al. |
Q47622097 | Introductory Commentary on The Role of Stromal Integrin Interactions in Pro-B-Cell Proliferation Hahn et al. |
Q52771944 | Inverse relationship between vitamin D levels and platelet indices in Korean adults. |
Q40418741 | Investigation of T-cell immunoglobulin- and mucin-domain-containing molecule-3 (TIM-3) polymorphisms in essential thrombocythaemia (ET). |
Q33369164 | Investigation of persistent hypochromic microcytosis unmasks hemoglobin Evanston [alpha 14 (A12) Try--> Arg] in a patient of cyclic thrombocytopenia preceding Takayasu's disease |
Q33435991 | Investigation of platelet apoptosis in adult patients with chronic immune thrombocytopenia |
Q48049196 | Investigation of the differences between the Tibetan and Han populations in the hemoglobin-oxygen affinity of red blood cells and in the adaptation to high-altitude environments. |
Q92437769 | Investigation on glucocorticoid receptors within platelets from adult patients with immune thrombocytopenia |
Q52134106 | Involvement of E-cadherin in the Development of Erythroid Cells; Subject Heading. |
Q39843818 | Involvement of Rap-1 activation and early termination of immune synapse in CTLA-4-mediated negative signal |
Q47396530 | Involvement of oncogenic tyrosine kinase NPM-ALK in trifluoperazine-induced cell cycle arrest and apoptosis in ALK(+) anaplastic large cell lymphoma |
Q85493882 | Iranian experience of deferasirox (Exjade(®)) in transfusion-dependent patients with iron overload: what is the most effective dose based on serum ferritin levels? |
Q54403775 | Iron Deficiency Anemia Associated with an Error of Iron Metabolism in Two Siblings: A Thirty Year Follow Up. |
Q87901921 | Iron Deficiency Developing in Patients with Homozygous Hypercholesterolaemia on Long-term Plasmapheresis is Significantly Contributed to by Extracorporeal Haemolysis |
Q50623726 | Iron deficiency anaemia and evaluation of the utility of iron deficiency indicators among healthy Nigerian children. |
Q85712294 | Iron deficiency anemia |
Q52594556 | Iron deficiency anemia referral to the hematologist. Real-world data from Mexico: the need for targeted teaching in primary care. |
Q28219478 | Iron deficiency in childhood and adolescence: retrospective review |
Q50711417 | Iron deficiency screening in the first three years of life: a three-decade-long retrospective case study. |
Q36270045 | Iron overload and chelation |
Q38476053 | Iron overload in transfusion-dependent thalassemia |
Q45753026 | Iron-chelation therapy with oral chelators in patients with thalassemia major |
Q45804415 | Is Friday leukemia a non-entity? |
Q47684140 | Is Granulocyte Colony-stimulating Factor Safe in the Treatment of Febrile Neutropenia in Lymphoma Patients with Renal Transplantation? |
Q86243271 | Is Pica under-reported in children with sickle cell disease? A pilot study in a Belgian cohort |
Q81409263 | Is assessment of surface CD38 expression worthwhile as a prognostic factor in chronic lymphocytic leukemia patients? |
Q39343047 | Is intensive monitoring during the first transfusion in pediatric patients necessary? |
Q48108637 | Is obstructive sleep apnoea syndrome really one of the causes of secondary polycythaemia? |
Q63241090 | Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin’s lymphoma in a developing country? |
Q47206772 | Is there a difference in phenotype between males and females with non-transfusion-dependent thalassemia? A cross-sectional evaluation |
Q35022123 | Is there a role for reduced-intensity haematopoietic stem cell transplantation for indolent non-Hodgkin's lymphoma? |
Q36746459 | Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs? |
Q81243482 | Isolated central nervous system relapse during cytologic and molecular hematologic remission in two patients with acute promyelocytic leukemia |
Q50452332 | Isolation and ex vivo expansion of human umbilical cord blood-derived CD34+ stem cells and their cotransplantation with or without mesenchymal stem cells. |
Q34637546 | JAK2 inhibitors and their impact in myeloproliferative neoplasms |
Q39162818 | JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia. |
Q83926743 | Jaundice and alpha gene triplication in beta-thalassemia: association or causation? |
Q81271196 | Juvenile myelomonocytic leukemia |
Q54649935 | KDR and Sema3 genes expression in bone marrow stromal cells and hematopoietic cells from leukemia patients and normal individuals. |
Q40212266 | Kidney injury in infants and children with iron-deficiency anemia before and after iron treatment |
Q44440140 | Kinetics of hematopoiesis in bone marrow cultures from patients with chronic myeloid leukemia: effect of recombinant cytokines in dexter-type long-term cultures |
Q87878037 | Kleihauer Testing and Flow Cytometry. A Comparative Study for Assessment of Feto-Maternal Haemorrhage |
Q47666357 | Knockdown of REGγ inhibits the proliferation and migration and promotes the apoptosis of multiple myeloma cells by downregulating NF-κB signal pathway |
Q44108314 | L and E selectins in acute myeloid leukemia: expression, clinical relevance and relation to patient outcome |
Q51790001 | Labile plasma iron, more practical and more sensitive to iron overload in myelodysplastic syndromes. |
Q44688146 | Lamivudine therapy in acute leukemia patients who are hepatitis B surface antigen carriers |
Q87979306 | Langerhans cell histiocytosis: differences and similarities in long-term outcome of paediatric and adult patients at a single institutional centre |
Q74000719 | Late Effects of Hematopoietic Stem Cell Transplantation; Bone Marrow Transplantation |
Q87879796 | Late Relapse After Allogeneic Bone Marrow Transplant In a Patient With Myelodysplasia |
Q36270122 | Late effects of hematopoietic stem cell transplantation |
Q37791617 | Lenalidomide: a synthetic compound with an evolving role in cancer management |
Q87879354 | Leucocyte Immunophenotyping: The Need for Standardization |
Q79358880 | Leukemia associated clonal expansion of TCR Vbeta subfamily T cells |
Q37212366 | Leukemic infiltration of the breast in acute lymphocytic leukemia (ALL). |
Q39939249 | Ligation of CD44 leads to killing activity in human peripheral mononuclear cells via MAP kinase and tyrosine kinases |
Q39820261 | Ligation of CD44 with low-molecular-weight hyaluronan and a monoclonal antibody leads to inhibition of drug-induced apoptosis in a human myeloid cell line |
Q46156541 | Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden |
Q46590378 | Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children |
Q92144057 | LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells |
Q104682091 | Long non-coding RNA MALAT1 modulate cell migration, proliferation and apoptosis by sponging microRNA-146a to regulate CXCR4 expression in acute myeloid leukemia |
Q91145654 | Long non-coding RNAs MALAT1, MIAT and ANRIL gene expression profiles in beta-thalassemia patients: a cross-sectional analysis |
Q42714159 | Long term curative effects of sequential therapy with all-trans retinoic acid, arsenious oxide and chemotherapy on patients with acute promyelocytic leukemia |
Q43934706 | Long-term effects of an oral iron chelator, deferasirox, in hemodialysis patients with iron overload |
Q46490988 | Long-term efficacy of oral deferiprone in management of iron overload in beta thalassemia major. |
Q84349986 | Long-term results of placental blood allografting using reduced-intensity conditioning: multicenter experience in a developing country |
Q90590794 | Long-term safety and efficacy of deferasirox in patients with myelodysplastic syndrome, aplastic anemia and other rare anemia in Taiwan |
Q48503097 | Low expression of Mda-7/IL-24 and high expression of C-myb in tumour tissues are predictors of poor prognosis for Burkitt lymphoma patients. |
Q51460184 | Low oxygen saturation and severe anemia in compound heterozygous Hb Louisville [β42(CD1)Phe→Leu] and Hb La Desirade [β129(H7)Ala→Val]. |
Q38990530 | Low turnover bone disease in Egyptian children with acute leukemia |
Q51795374 | Low-dose lenalidomide and dexamethasone combination treatment in elderly patients with relapsed and refractory multiple myeloma. |
Q33406040 | Low-dose rituximab for the treatment of acute thrombotic thrombocytopenic purpura: report of four cases |
Q33413790 | Low-dose rituximab in the treatment of acquired haemophilia |
Q33431511 | Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP. |
Q44703351 | Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemia |
Q33373655 | Lupus anticoagulant and anticardiolipin antibodies in polytransfused beta thalassemia major |
Q86979692 | Lymphoid neoplasms |
Q42979416 | Lymphomas and leukemias due to infectious organisms |
Q44544162 | MAGE-A3 expression is an adverse prognostic factor in diffuse large B-cell lymphoma |
Q48506102 | MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. |
Q47684280 | Macrophage Inflammatory Protein-1 Alpha: A Paradox? |
Q46600569 | Macrophages promote development of human erythroid precursors in transferrin-free culture medium |
Q40714865 | Mad2 overexpression is associated with high cell proliferation and reduced disease-free survival in primary gastrointestinal diffuse large B-cell lymphoma |
Q87896680 | Maintenance Therapy with Interferon Alfa 2b Improves Outcome in Aggressive Malignant Lymphoma |
Q33343830 | Major histocompatibility complex susceptibility genes and immune thrombocytopenic purpura in Caucasian adults |
Q33401582 | Malaria: a haematological disease |
Q101453994 | Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center |
Q74000565 | Malignancy: 2'-Chlorodeoxyadenosine Effectively Induces Complete Remission in Hairy Cell Leukaemia |
Q74000450 | Malignancy: A New Approach to the Analysis of Apoptosis in the Leukemic Subpopulation by Flow Cytometry Using a CD45 Gating Strategy |
Q74000605 | Malignancy: Adjuvant Radiotherapy to Initial Bulky Disease in Patients with Advanced Stage Hodgkin's Disease |
Q74000571 | Malignancy: Case Report: Acute Promyelocytic Leukemia in Late Pregnancy. Successful Treatment with All-Trans-Retinoic Acid (ATRA) and Chemotherapy |
Q34278254 | Malignancy: Case Report: Hypereosinophilia Progressing to Granulocytic Sarcoma and Acute Myelocytic Leukemia with Trisomy 8: A Case Report and Review of the Literature |
Q34278245 | Malignancy: Case Report: Muscle Involvement in Multiple Myeloma: Report of a Patient Presenting Clinically as Polymyositis |
Q34278260 | Malignancy: Case report: Myelodysplasia Following Treatment of Chronic Lymphocytic Leukaemia with Fludarabine. |
Q74000660 | Malignancy: Changes in Circulating Immature and Mature Dendritic Cells During IL-2 Cancer Immunotherapy and Their Relation with Lymphocyte Increase and Clinical Response |
Q74000445 | Malignancy: Current Clinical Practice: Current Therapeutic Options in Myelodysplastic Syndromes |
Q74000512 | Malignancy: Current Clinical Practice: Treatment of Hairy Cell Leukemia at the Close of the 20th Century |
Q34278291 | Malignancy: Gene Therapy Vaccines in Acute Myeloid Leukemia : A Need for Clinical Evaluation |
Q40601458 | Malignancy: Granulocyte Colony Stimulating Factor Increases the Efficacy of Conventional Amphotericin in the Treatment of Presumed Deep-Seated Fungal Infection in Neutropenic Patients following Intensive Chemotherapy or Bone Marrow Transplantation f |
Q45736983 | Malignancy: Human T-Cell Lymphotropic Virus Type I and Adult T-Cell Leukaemia/Lymphoma |
Q74000643 | Malignancy: Identification of Predictors of Disease Status and Progression in Patients with Myeloma (MM) |
Q74000601 | Malignancy: Idiotypic Immune Targeting of Multiple Myeloma |
Q74000482 | Malignancy: Insulin-like Growth Factor-1 (IGF-1) is a Costimulator of the Expansion of Lineage Committed Cells Derived from Peripheral Blood Mobilized CD34+ Cells in Multiple Myeloma Patients |
Q34278277 | Malignancy: Meningeal Myeloma: A Case Report and Review of Literature |
Q55034869 | Malignancy: Molecular Demonstration of BCR/ABL Fusion in a Patient with Chronic Myelogenous Leukemia with Basophilia Carrying a Variant t(16;22) (q24;q11) Philadelphia Chromosome. |
Q74000636 | Malignancy: Myeloma - the Elusive Cure |
Q74000418 | Malignancy: Subsequential Alterations of Telomeric DNA Length Correlate with Cytogenetic Response in Chronic Myeloid Leukemia Treated with Interferon alpha |
Q74000490 | Malignancy: The Number of Nucleoli and Main Nucleolar Types in Lymphoblasts of Children Suffering from Acute Lymphoid Leukemia |
Q34278271 | Malignancy: Tumor Suppressor Gene Aberrations in Acute Myelogenous Leukemia |
Q44485225 | Malignancy: X-Linked Cytochrome B Positive Chronic Granulomatous Disease treated by Bone Marrow Transplantation |
Q74000665 | MalignancyCase Report: Systemic Sarcoidosis Preceeding Acute Myeloid Leukemia |
Q53745563 | Management of Aplasia. |
Q30843420 | Management of Hodgkin's lymphoma with midbrain involvement: A case report and review of literature |
Q28167261 | Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillation |
Q36194564 | Management of bleeding in the terminally ill patient |
Q36270118 | Management of invasive fungal infections in neutropenic patients |
Q54278466 | Management of the Chronic Leukemias: Special Considerations in the Elderly Patient. Part I. Chronic Lymphocytic Leukemias. |
Q38894184 | Management of the Chronic Leukemias: Special Considerations in the Elderly Patient. Part II: Chronic Granulocytic Leukemia |
Q34780619 | Management of the chronic leukemias: special considerations in the elderly patient. Part III rarer chronic myeloid leukemias |
Q37372868 | Management of transfusional iron overload in Latin America: current outlook and expert panel recommendations |
Q82653401 | Manual and automated reticulocyte counts |
Q53759833 | Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera. |
Q80454226 | Markers of apoptosis and proliferation related gene products as predictors of treatment outcome in childhood acute lymphoblastic leukemia |
Q81203958 | Massive deep venous thrombosis and venous gangrene in a 29-year-old case: metastatic epidermoid carcinoma with an unknown primary |
Q41584606 | Matched sibling donors versus alternative donors in allogeneic hematopoietic stem cell transplantation for pediatric severe aplastic anemia in México |
Q57806533 | Maternal sickle cell disease and twin pregnancy: a case series and review of the literature |
Q47624319 | Matrix Metalloproteinases |
Q47683108 | Matrix Metalloproteinases in the Hematopoietic Microenvironment |
Q33433839 | Mean Platelet Volume in Thrombocytopenic, Preterm Infants |
Q88315285 | Mean platelet volume at baseline and immune thrombocytopenia relapse in Chinese newly-diagnosed patients: a retrospective cohort study |
Q80559452 | Mean platelet volume measurement, EDTA or citrate? |
Q46150811 | Measurement of Th1, Th2 cytokines and white cell count in childhood haemoglobinopathies with uncomplicated malaria infection |
Q40081650 | Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells |
Q40799496 | Megakaryocytic Maturation is Regulated by Maintaining a Balance Against Cytokine Induced-cell Proliferation: Steel Factor Retards Thrombopoietin-induced Megakaryocytic Differentiation While Synergistically Stimulating Mitogenesis; Hematopoiesis |
Q85900597 | Megakaryocytic differentiation of CD133+ hematopoietic stem cells by down-regulation of microRNA-10a |
Q36270106 | Megaloblastic Anaemia (MA). |
Q46570611 | Meningioma 1 (MN1) expression: refined risk stratification in acute myeloid leukemia with normal cytogenetics (CN-AML). |
Q46214607 | Meta-analysis of all-trans retinoic acid-linked arsenic trioxide treatment for acute promyelocytic leukemia |
Q53161925 | Meta-analysis on effectiveness of hydroxyurea to treat transfusion-dependent beta-thalassemia. |
Q53785420 | Methimazole-Induced Agranulocytosis and Quick Recovery with G-CSF. |
Q48175363 | Methionine synthase reductase deficiency (CblE): A report of two patients and a novel mutation. |
Q44354498 | Methotrexate-induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico |
Q54266084 | Methylation status of CEBPA gene promoter in chronic myeloid leukemia. |
Q39337531 | Methylprednisolone induces apoptosis by interacting with the JAK/STAT pathway in HL-60 and K-562 leukemic cells |
Q54515813 | Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen. |
Q38954464 | MicroRNA-21 is involved in X-ray irradiation resistance in K562 leukaemia cells |
Q38015971 | MicroRNAs in hematological malignancies: a novel approach to targeted therapy |
Q87879800 | Microangiopathic Hemolytic Anemia Associated with the use of both Cyclosporin A and FK506 (Tacrolimus) in the Same Patient |
Q39448190 | Microsatellite Instability and Promoter Hypermethylation of DNA repair genes in Hematologic Malignancies: a forthcoming direction toward diagnostics |
Q83903754 | Minimal disease detection of B-cell lymphoproliferative disorders by flow cytometry: multidimensional cluster analysis |
Q57788892 | Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission |
Q91536117 | Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia |
Q91964255 | Minimal residual disease may be an early prognostic indicator for newly diagnosed acute myeloid leukemia patients induced by decitabine-based chemotherapy |
Q89547246 | Mitochondrial ferritin expression in erythroid cells from patients with alpha-thalassaemia |
Q45753490 | Mitral valve surgery in severe congenital factor VII deficiency |
Q46175818 | Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma. |
Q50761044 | Modeling for tertiary structure of globin chain in Hemoglobin Suan-Dok disorder. |
Q39608150 | Moderate hyperprolactinemia is associated with survival in patients with acute graft-versus-host disease after allogeneic stem cell transplantation. |
Q39851542 | Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia |
Q37618337 | Modern concepts in the treatment of chronic lymphocytic leukemia |
Q46490986 | Modified IDARAM chemotherapy regimen for primary central nervous system lymphoma: experience of three cases |
Q52723326 | Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell disease. |
Q38894494 | Modulation of Platelet Aggregation Response by Factors Released from Polymorphonuclear Leukocytes |
Q47330431 | Modulation of hepcidin expression by normal control and beta0-thalassemia/Hb E erythroblasts. |
Q58001051 | Molecular Cytogenetic Analysis of B-CLL Patients with Aggressive Disease |
Q44932470 | Molecular Medicine and Molecular Pathology for Haematologists: I. Gene Speak made Easy: An Overview of Genes and Gene Expression |
Q74000458 | Molecular Medicine and Molecular Pathology for Hematologists: II. Lets go Techno; Principles of the Molecular Technologies and their Applications in Haematology |
Q38894040 | Molecular Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria |
Q87911409 | Molecular Pathology of Thalassemia and Triplicated Locus in North Indian Population; Interaction with Heterozygous Thalassemia |
Q47976021 | Molecular analysis of abnormal hemoglobins in beta chain in Aegean region of Turkey and first reports of hemoglobin Andrew-Minneapolis and Hb Hinsdale from Turkey |
Q87328708 | Molecular analysis of patients with severe congenital factor X deficiency: First report from north and northwest of Iran |
Q37183513 | Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia |
Q38952102 | Molecular and clinical analysis of haemoglobin Lepore in Campania, a region of Southern Italy |
Q37737808 | Molecular basis of hereditary iron homeostasis defects |
Q35022121 | Molecular biology of gastric MALT lymphoma: application in clinical management |
Q38003013 | Molecular biology strategies to detect residual disease |
Q62583488 | Molecular characterization of chronic myeloproliferative neoplasias in México |
Q45961847 | Molecular diagnosis and prognosis with DNA microarrays. |
Q83903734 | Molecular genetics of acute myeloid leukemia: clinical implications and opportunities for integrating genomics into clinical practice |
Q35670986 | Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis |
Q83926729 | Molecular immunoglobulin/T-cell receptor clonality diagnosis by gene scan in lymphoproliferative disorders |
Q35197150 | Molecular markers in myeloproliferative disorders: from classification to prognosis? |
Q38074249 | Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia |
Q35668677 | Molecular monitoring of minimal residual disease in patients with multiple myeloma |
Q54566418 | Molecular pathogenesis and clinical variability of homozygous beta0-thalassemia in populations of Jammu region of J&K state (India). |
Q38003012 | Molecular targeted therapy in acute myeloid leukemia |
Q84753703 | Molecular variants and clinical importance of beta-thalassaemia traits found in the state of Orissa, India |
Q50052828 | Mometasone furoate inhibits growth of acute leukemia cells in childhood by regulating PI3K signaling pathway. |
Q35080331 | Monitoring of low molecular weight heparin in pregnancy |
Q40184741 | Monoclonal B-cell lymphocytosis in blood donors in Turkey |
Q83903745 | Monoclonal antibodies in adult acute lymphoblastic leukemia |
Q33400764 | Monoclonal antibodies in the treatment of immune thrombocytopenic purpura (ITP). |
Q38896604 | Monocyte and Haemostasis |
Q53544513 | Monocytosis is associated with hemolysis in sickle cell disease. |
Q33430243 | More about low-dose rituximab and plasma exchange as front-line therapy for patients with thrombotic thrombocytopenic purpura. |
Q33437618 | More on the thrombocytopenia of the non-alcoholic fatty liver disease |
Q39355501 | Morpholino Oligo Antisense efficiently suppresses BCR/ABL and cell proliferation in CML: specific inhibition of BCR-ABL gene expression by Morpholino Oligo Antisense in BCR-ABL(+) cells |
Q36270054 | Morphology in the diagnosis of red cell disorders |
Q36074388 | Moving the Frontiers of Cancer Chemotherapy for Solid Tumors by Changing the Scope of Drug Development |
Q47327051 | Mu-heavy chain disease associated with systemic amyloidosis |
Q87926784 | Multidrug resistance 1 (MDR1/ABCB1) gene polymorphism (rs1045642 C > T) and susceptibility to multiple myeloma: a systematic review and meta-analysis |
Q40081644 | Multidrug resistance inhibition by antisense oligonucleotide against MDR1/mRNA in P-glycoprotein expressing leukemic cells |
Q87912108 | Multiple Myeloma Presenting with Crystal Deposition in the Bone Marrow |
Q46600575 | Multiple littoral cell angioma of the spleen in a case of myelodysplastic syndrome |
Q86561572 | Multiple myeloma |
Q44354524 | Multiple myeloma staging based on the combination of beta-2-microglobulin and albumin: the role of albumin in the model |
Q83903699 | Multiple myeloma: treatment evolution |
Q36687989 | Multiply relapsing hairy cell leukemia responsive to repeated courses of rituximab: a case report |
Q41923461 | Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis |
Q91628708 | Multivariate logistic analysis of predictors of response to immunosuppressive therapy in children with aplastic anemia: a double-center study |
Q96021437 | Mutational landscape of patients with acute myeloid leukemia or myelodysplastic syndromes in the context of RUNX1 mutation |
Q74597212 | Mutations in the p53 gene in acute myeloid leukemia patients correlate with poor prognosis |
Q41698364 | Myeloablative haploidentical hematopoietic stem cell transplantation using basiliximab for graft-versus-host disease prophylaxis |
Q85712299 | Myelodysplasia |
Q38897894 | Myelodysplasia Following Treatment of Chronic Lymphocytic Leukaemia with Fludarabine |
Q33345617 | Myelodysplasia and the acute myeloid leukaemias |
Q33376659 | Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature |
Q43727366 | Myelodysplastic syndromes: classification and prognostic scoring systems and their applicability in Indian scenario-experience from a tertiary care center |
Q87417742 | Myelofibrosis |
Q50676888 | Myelofibrosis with myeloid metaplasia in a patient with relapsed Hodgkin's lymphoma who underwent autologous hematopoietic stem cell transplantation. |
Q87896685 | Myeloid Leukemia After Cytotoxic Therapy and Other Hematotoxins |
Q47625068 | Myeloma Presenting in the Base of the Skull |
Q46272130 | Myeloma Presenting with Massive Splenomegaly |
Q81271143 | Myeloma bone disease |
Q48452296 | Myeloma: diagnosis complications and supportive care. |
Q74000559 | Myeloproliferative Disease: Markers of Endothelial and Platelet Status in Patients with Essential Thrombocythemia and Polycythemia Vera |
Q53324816 | Myeloproliferative Disease: Polycythemia Vera: The Packed Cell Volume and The Curious Logic of The Red Cell Mass. |
Q96612056 | Myeloproliferative neoplasms treated with hydroxyurea, pegylated interferon alpha-2A or ruxolitinib: clinicohematologic responses, quality-of-life changes and safety in the real-world setting |
Q50462408 | Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma. |
Q98387827 | Mélange intéressante: COVID-19, autologous transplants and multiple sclerosis |
Q53270482 | NK-cell neoplasms in Japan. |
Q44959828 | NPM1, FLT3-ITD, CEBPA, and c-kit mutations in 312 Chinese patients with de novo acute myeloid leukemia |
Q37383687 | Near-infrared spectra absorbance of blood from sickle cell patients and normal individuals |
Q46374593 | Nephrotic syndrome associated with chronic lymphocytic leukaemia |
Q46929634 | Neurocognitive dysfunction in children with β thalassemia major: psychometric, neurophysiologic and radiologic evaluation. |
Q82754988 | Neurofibromatosis type I and smoldering multiple myeloma: a case report |
Q74000748 | Neurosarcoidosis Associated with Hodgkin's Disease; Malignancy |
Q36828921 | Neutropenia and G-CSF in lymphoproliferative diseases |
Q28203932 | Neutrophil elastase mutations in congenital neutropenia |
Q58134897 | New ISH website |
Q91628717 | New data on FII, FV, FIX and thrombomodulin defects: blood keeps clotting in normal and in peculiar ways |
Q36270022 | New development in anticoagulant and antithrombotic therapy: are we on the right track? |
Q83903778 | New developments in the field of diffuse large cell lymphoma |
Q38003014 | New developments in the management of diffuse large B-cell lymphoma |
Q81243535 | New insights into paroxysmal nocturnal hemoglobinuria |
Q30929503 | New strategies for BMT, organ transplantation, and regeneration therapy |
Q43173262 | Nilotinib significantly induces apoptosis in imatinib-resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts |
Q50665720 | Ninety-six suspected transfusion related acute lung injury cases: investigation findings and clinical outcome. |
Q74000793 | Nitric Oxide Metabolites in Sickle Cell Anemia Patients after Oral Administration of Hydroxyurea; Hemoglobinopathy |
Q33382856 | Nitric oxide in immune thrombocytopenic purpura |
Q53810729 | Nitrite and Nitrate Plasma Levels, as Markers for Nitric Oxide Synthesis, in Thrombotic Thrombocytopenic Purpura (TTP). |
Q44108317 | No cytomegalovirus-related deaths after non-ablative stem cell allografts |
Q87876335 | Nocardiosis Causing Hypocellular Bone Marrow after Allogeneic Peripheral Blood Stem Cell Transplantation |
Q87912111 | Non-inpatient Treatment of Febrile Episodes in Patients with Hematological Malignancy |
Q63241096 | Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience |
Q39379442 | Non-pharmacologic management of sickle cell pain |
Q84349974 | Non-random chromosomal deletion clustering at 20q in Waldenström macroglobulinemia |
Q93216314 | Noninvasive assessment and risk factors of liver fibrosis in patients with thalassemia major using shear wave elastography |
Q59629334 | Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors |
Q104138612 | Normal activated partial thromboplastin time in Chinese patients with mild hemophilia B |
Q93349043 | Notice of Duplicate Publication |
Q52867582 | Novel Haematological Parameters in Patients Receiving Recombinant Human Erythropoietin and Undergoing Haemodialysis. |
Q49849870 | Novel interactions of two α-Hb variants with SEA deletion α(0)-thalassemia: hematological and molecular analyses. |
Q51747462 | Novel mutation (R192C) in CYB5R3 gene causing NADH-cytochrome b5 reductase deficiency in eight Indian patients associated with autosomal recessive congenital methemoglobinemia type-I. |
Q83903737 | Novel therapeutic strategies for AML in 2012 |
Q34637538 | Novel therapeutics in multiple myeloma |
Q38003015 | Novel therapies in monoclonal gammopathies |
Q57904916 | Novel treatments of multiple myeloma |
Q39015645 | Nucleostemin knocking-down causes cell cycle arrest and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells via p53 and p21Waf1/Cip1 up-regulation. |
Q39004780 | Number of parity and the risk of non-Hodgkin lymphomas: a dose-response meta-analysis of observational studies |
Q38746865 | Nutritional status in children and adolescents with leukemia: An emphasis on clinical outcomes in low and middle income countries |
Q48336293 | Occupational, dietary, and other risk factors for myelodysplastic syndromes in Western Greece |
Q89293152 | Octamer-binding transcription factor 4 correlates with complex karyotype, FLT3-ITD mutation and poorer risk stratification, and predicts unfavourable prognosis in patients with acute myeloid leukaemia |
Q53176650 | Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. |
Q33371425 | Onset of severe refractory thrombocytopenia following surgery in a patient with type 2B von Willebrand disease--a case report |
Q45886996 | Optimal length of time of cryopreserved umbilical cord blood infusion after thawing |
Q39979643 | Optimal therapy for polycythemia vera and essential thrombocythemia: Preferred use of interferon therapy based on phase 2 trials |
Q87878285 | Optimising Treatment for Elderly Patients with Acute Leukaemia |
Q36270110 | Optimizing clotting factor replacement therapy in hemophilia: a global need |
Q35173183 | Oral mucositis: time for more studies |
Q52180946 | Osteoblasts and The Hematopoietic Microenvironment. |
Q47624307 | Osteogenesis and The Microenvironment. |
Q37212358 | Osteomyelosclerosis with thalassemia trait: report of a rare association, study of platelet function tests and review of literature |
Q35126992 | Outcome and toxicity of salvage treatment on patients relapsing after autologous hematopoietic stem cell transplantation--experience from a single center. |
Q50873125 | Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey. |
Q39510856 | Outcome of childhood acute Lymphoblastic leukemia in Egyptian children: a challenge for limited health resource countries. |
Q36939568 | Outcome of pregnancy in women treated with all-trans retinoic acid; a case report and review of literature |
Q43554766 | Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia |
Q92424209 | Outcomes of unplanned tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: retrospective analysis of real-world experience in a single institution |
Q43258162 | Outpatient consolidation chemotherapy in pediatric acute myeloid leukemia: a retrospective analysis |
Q42511622 | Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). |
Q46900406 | Over expression of HIF-1α in human mesenchymal stem cells increases their supportive functions for hematopoietic stem cells in an experimental co-culture model. |
Q87879614 | Owen Stuart Roath (1929-1997) |
Q46214480 | Oxidative crosslinking, spectrin and membrane interactions of hemoglobin mixtures in HbEbeta-thalassemia |
Q46429946 | Oxidative process in erythrocytes of individuals with hemoglobin S. |
Q38861109 | Oxidative stress in erythrocytes of banked ABO blood |
Q90235401 | Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children |
Q87912909 | P-Glycoprotein Expression in Acute Myeloid Leukaemia Cells at Diagnosis: Its relationship to Daunorubicin or Idarubicin Induction Therapy and Survival |
Q74000805 | P-Glycoprotein Expression in Acute Myeloid Leukaemia Cells at Diagnosis: Its relationship to Daunorubicin or Idarubicin Induction Therapy and Survival; Malignancy |
Q46979570 | P-glycoprotein (P-170) expression in acute leukemias |
Q89372545 | PD-1 blockade potentially enhances adoptive cytotoxic T cell potency in a human acute myeloid leukaemia animal model |
Q87878296 | Parenteral Iron and Recombinant Human Erythropoietin Therapy to Stimulate Erythropoiesis in Patients Undergoing Repair of Hip Fracture |
Q50711129 | Parvovirus B-19 induced acute pure red cell aplasia in patients with chronic lymphocytic leukemia and neurofibromatosis type-1. |
Q39621941 | Parvovirus B19 infection in children with a variety of hematological disorders |
Q46241407 | Parvovirus and herpes simplex association with unexplained anemia in pregnancy: a prospective study |
Q45856316 | Pathogenesis and Management of Acquired Haemophilia |
Q87903091 | Pathogenesis of Autoimmune Diseases in Large Granular Lymphocyte Leukemia |
Q87899096 | Pathogenesis of Hyperhomocysteinemia-New Insights |
Q38896695 | Pathogenesis of Idiopathic Myelofibrosis: A Review |
Q87878025 | Pathogenesis of Thrombotic Complications of Haematological Malignancies |
Q91964196 | Pathogenesis of aplastic anemia |
Q41073900 | Pathogenetic Aspects of Myelodysplastic Syndromes |
Q47201190 | Pathogenicity analysis of variations and prenatal diagnosis in a hereditary coagulation factor XIII deficiency family |
Q36328383 | Patient understanding of warfarin therapy: a review of education strategies |
Q86625862 | Patient-specific microRNA expression profiles as a marker for minimal residual disease in acute myeloid leukemia |
Q45866290 | Pattern of factor VIII inhibitors in patients with hemophilia A in the north east of Iran |
Q87426774 | Pattern of immunoglobulin and T-cell receptor-δ/γ gene rearrangements in Iranian children with B-precursor acute lymphoblastic leukemia |
Q38855966 | Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience |
Q28248388 | Pearson syndrome in an infant heterozygous for C282Y allele of HFE gene |
Q91162536 | Pediatric mature B-cell NHL, early referral and supportive care problems in a developing country |
Q40702666 | Pentoxifylline, Ciprofloxacin and Dexamethasone Improve the Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients; Malignancy |
Q53133828 | Peripheral and bone marrow CD34+ cell levels on chronic myeloproliferative disease. |
Q79358887 | Persistent questions about the treatment of severe aplastic anemia in children as illustrated by five cases |
Q40484494 | Persistent splenomegaly in an adult female with homozygous sickle cell anemia. |
Q74816930 | Peyronie's disease as a complication of chronic graft versus host disease |
Q34327594 | Pharmacogenomics of MDR1/ABCB1 gene: the influence on risk and clinical outcome of haematological malignancies |
Q92090644 | Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency |
Q35809469 | Pharmacological induction of fetal hemoglobin synthesis using histone deacetylase inhibitors |
Q58148282 | Phenotype and TCR-gamma gene rearrangements in a Malaysian cohort of T-cell leukaemia/lymphoma cases |
Q47624329 | Phenotypic and Functional Characterization of Human Marrow Vascular Stromal Cells |
Q113848426 | Phenotypic and genetic analyses of four cases of coagulation factor XII deficiency |
Q50893727 | Phenotypic and genetic analysis of dysprothrombinemia due to a novel homozygous mutation. |
Q33369158 | Philadelphia chromosome positive acute lymphoblastic leukemia showing normal karyotype in G-banding chromosomal examination before chemotherapy |
Q38635161 | Philadelphia chromosome-positive Acute Lymphoblastic Leukemia |
Q46374584 | Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcome |
Q47328529 | Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients. |
Q47683143 | Phosphorylation of the Retinoblastoma Protein in Childhood Acute Lymphoblastic Leukemia |
Q89785365 | Physical exercise is safe and feasible in thrombocytopenic patients with hematologic malignancies: a narrative review |
Q38042778 | Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia |
Q38003010 | Planetary change and biochemical adaptation: molecular evolution of corrinoid and heme biosyntheses. |
Q30640505 | Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population). |
Q50505015 | Plasma Proteins Case Report: Massive Bone Marrow Necrosis with Polyclonal Hypergammaglobulinemia and Blue Toe Syndrome. |
Q84299401 | Plasma cell leukemia--a study of 28 cases from India |
Q91354543 | Plasma fibrinogen level as possible prognostic biomarker in diffuse large B-cell lymphoma |
Q44765608 | Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea |
Q46844319 | Plasma levels of some blood coagulation parameters in Nigerian homozygous sickle cell patients (HbSS) in steady state |
Q53705061 | Platelet Activation in Hypercholesterolemic Patients Submitted to Therapeutic Plasmapheresis. An Ultrastructural Study. |
Q33403314 | Platelet count and serum thrombopoietin level as predictors for morbidity and/or mortality in thrombocytopenic neonates |
Q33349456 | Platelet count increase following phlebotomy in iron overloaded patients with liver cirrhosis |
Q33358034 | Platelet counts and interleukin-6 (IL-6) promoter polymorphism in patients with Gaucher disease |
Q84925680 | Platelet distribution width as an indicator of microvascular complications in type 2 diabetic patients |
Q33432087 | Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk |
Q36270009 | Platelet function testing in cardiovascular diseases |
Q46556370 | Platelet function testing in uraemic patients |
Q83649605 | Platelet indices in diabetes mellitus: indicators of diabetic microvascular complications |
Q36270004 | Platelets in sepsis |
Q45038109 | Ploidy Analysis and Ki-67 Expression in Myelodysplastic Syndromes |
Q87903565 | Point of Care Testing in Haematology |
Q87046419 | Polycythaemia vera |
Q54141441 | Polycythemia Vera: The Packed Cell Volume and The Curious Logic of The Red Cell Mass. |
Q41178645 | Polymorphic variants of GSTM1, GSTT1, and GSTP1 genes in childhood acute leukemias: A preliminary study in Argentina |
Q57176443 | Polymorphisms in the TGF-β1 (rs1982037) and IL-2 (rs2069762, rs4833248) genes are not associated with inhibitor development in Iranian patients with hemophilia A |
Q39145866 | Positive selection of Wharton's jelly-derived CD105(+) cells by MACS technique and their subsequent cultivation under suspension culture condition: A simple, versatile culturing method to enhance the multipotentiality of mesenchymal stem cells |
Q48328481 | Positron emission tomography computed tomography features of monomorphic epitheliotropic intestinal T-cell lymphoma |
Q89459888 | Possible association of 3' UTR +357 A>G, IVS11-nt 93 T>C, c.1311 C>T polymorphism with G6PD deficiency |
Q87879358 | Post Chernobyl Hemoblastoses in the Republic of Belarus (brief communication) |
Q79964247 | Post-gastrectomy anemia: evaluation of 72 cases with post-gastrectomy anemia |
Q38756198 | Post-therapeutic recovery of serum interleukin-35 level might predict positive response to immunosuppressive therapy in pediatric aplastic anemia |
Q40232543 | Potential over request in anemia laboratory tests in primary care in Spain. |
Q90175424 | Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients |
Q48114774 | Pre-transplantation thymic function is associated with the risk of acute graft versus host disease and cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation. |
Q46429951 | Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia |
Q88922136 | Predictive factors of daily opioid use and quality of life in adults with sickle cell disease |
Q40439520 | Predictive factors of septic shock and mortality in neutropenic patients |
Q47413364 | Predictive parameters for imatinib failure in patients with chronic myeloid leukemia. |
Q43173266 | Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation |
Q41578520 | Predictive value of F-18 FDG PET/CT quantization parameters for progression-free survival in patients with diffuse large B-cell lymphoma |
Q86802090 | Preeclampsia: are platelet count and indices useful for its prognostic? |
Q35670982 | Pregnancy associated aplastic anemia--a series of 10 cases with review of literature |
Q38570916 | Pregnancy in beta-thalassemia trait carriers: an uneventful journey |
Q87940371 | Preliminary investigation about the expression of tubulin in platelets from patients with iron deficiency anemia and thrombocytosis |
Q87879060 | Prenatal Diagnosis of β-Thalassemia Using Multiplex Allele-Specific Amplification (MASPCR) in Chinese Families |
Q38194607 | Preoperative transfusion in patients with sickle cell disease to prevent perioperative complications: a systematic review and meta-analysis. |
Q35605120 | Preparative therapies used for those with Fanconi's anemia undergoing stem cell transplants and subsequent engraftment rates |
Q88393101 | Pretransplant serum FT3 levels in recipients predict early non-relapse mortality after myeloablative allogeneic haematopoietic cell transplantation from matched sibling donors |
Q104566998 | Pretreatment grade 4 thrombocytopenia is an independent prognostic factor in adult acute lymphoblastic leukemia: an extended analysis of a single-center retrospective study |
Q53164864 | Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia. |
Q93385627 | Prevalence and clinical significances of red cell alloimmunization and red cell bound immunoglobulin G in polytransfused patients with thalassemias |
Q31111317 | Prevalence and cumulative 5-year incidence of chronic lymphocytic leukemia in the adult population in the Russian Federation and Ukraine: Data from the LEUKOSPECT study. |
Q41467048 | Prevalence of hemoglobin E in Yunnan Province of Southwest China |
Q51945410 | Prevalence of iron deficiency anemia among adolescent schoolgirls from Kermanshah, Western Iran. |
Q50108312 | Prevalence of iron deficiency in a total joint surgery population. |
Q87876338 | Prevention of Bleeding Complications in Neonates With Liver Failure Undergoing Surgery Using Recombinant Factor VIIa |
Q86188033 | Prevention of acute GVHD in mice by treatment with Tripterygium hypoglaucum Hutch combined with cyclosporin A |
Q54107223 | Primary Hyperparathyroidism and Lymphoproliferative Diseases: Three Case Reports. |
Q38096667 | Primary bone marrow T-cell/histiocyte-rich large B-cell lymphoma: a diagnostic challenge |
Q24646477 | Primary chronic cold agglutinin disease: an update on pathogenesis, clinical features and therapy |
Q81450829 | Primary duodenal diffuse large cell non-hodgkin lymphoma with involvement of ampulla of Vater: report of 3 cases |
Q81243527 | Primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia: a prospective pilot trial using PFA-100 analysis to rationalize therapeutic LDL-apheresis procedure |
Q40492477 | Primary myelodysplastic syndrome in children--clinical, hematological and histomorphological profile from a tertiary care centre in India |
Q54266096 | Primary research on unrelated double umbilical cord blood transplantation and implantation kinetics. |
Q81973609 | Primary thrombophilia in México VII: the V617F mutation of JAK2 is not a frequent cause of thrombosis |
Q38457581 | Principles of the Polymerase Chain Reaction in Haematology |
Q53528283 | Procoagulant factors in patients with cancer. |
Q48118204 | Prognosis value of atrial natriuretic peptide and brain natriuretic peptide for heart failure in patients undergoing allogeneic bone marrow transplantation |
Q38316906 | Prognosis-related factors in intensive care unit (ICU) patients with hematological malignancies: A retrospective cohort analysis in a Chinese population |
Q39447794 | Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura Egypt |
Q39447801 | Prognostic cytogenetic markers in childhood acute lymphoblastic leukemia: cases from Mansoura, Egypt |
Q104470364 | Prognostic effect of RUNX1 mutations in myelodysplastic syndromes: a meta-analysis |
Q46737739 | Prognostic factors for outcomes of allogeneic stem cell transplantation in chronic phase chronic myeloid leukemia in the era of tyrosine kinase inhibitors |
Q102203754 | Prognostic factors for patients with multiple myeloma admitted to the intensive care unit |
Q35197154 | Prognostic factors in adult acute lymphoblastic leukemia |
Q47630011 | Prognostic factors in the survival of patients with blood disorders recovering from septic shock |
Q49838769 | Prognostic impact of CD200 and CD56 expression in adult acute lymphoblastic leukemia patients. |
Q39631733 | Prognostic impact of Wilms tumor gene mutations in Egyptian patients with acute myeloid leukemia with normal karyotype |
Q45900362 | Prognostic impact of serum 25-hydroxivitamin D [25(OH)D] concentrations in patients with lymphoid malignancies. |
Q39450821 | Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia |
Q89180620 | Prognostic significance of ASXL1 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: A meta-analysis |
Q53164854 | Prognostic significance of HOXB4 in de novo acute myeloid leukemia. |
Q58005555 | Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis |
Q96612064 | Prognostic significance of Twist, ZEB1 and Slug in peripheral T-cell lymphomas |
Q39273693 | Prognostic significance of WT1 expression at diagnosis and end of induction in Egyptian adult acute myeloid leukemia patients |
Q51759886 | Prognostic significance of immunohistochemical classification of diffuse large B-cell lymphoma. |
Q91058872 | Prognostic significance of monosomal karyotype in myelodysplastic syndrome: a meta-analysis |
Q104567066 | Prognostic value of RASD1 transcript levels in adult Philadelphia-negative B-cell acute lymphoblastic leukemia |
Q93092541 | Prognostic value of DNMT3A mutations in myelodysplastic syndromes: a meta-analysis |
Q51055200 | Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP. |
Q33375990 | Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review |
Q50542130 | Proposal of a score combining red blood cell indices for early differentiation of beta-thalassemia minor from iron deficiency anemia. |
Q87351689 | Proposed minimal panel of antibodies for cost-effectiveness and accuracy in acute leukemias immunophenotyping: Prospective study at a tertiary care center |
Q36270134 | Prospects for developing a molecular cure for thalassemia |
Q48214761 | Protector effect of α-thalassaemia on cholecystitis and cholecystectomy in sickle cell disease. |
Q47683809 | Protein Turnover, Energy Expenditure and Body Composition in Patients with Acute Leukaemia Undergoing Chemotherapy |
Q38043676 | Protein anticoagulants targeting factor VIIa-tissue factor complex: a comprehensive review |
Q36328401 | Protein palmitoylation in signal transduction of hematopoietic cells |
Q40081656 | Protein phosphatase 2A (PP2A) has a potential role in CAPE-induced apoptosis of CCRF-CEM cells via effecting human telomerase reverse transcriptase activity |
Q46970334 | Protein-coding genes and long noncoding RNAs are differentially expressed in dasatinib-treated chronic myeloid leukemia patients with resistance to imatinib |
Q47348288 | Protein-protein interaction networks and different clustering analysis in Burkitt's lymphoma |
Q90081262 | Proteomic tools and new insights for the study of B-cell precursor acute lymphoblastic leukemia |
Q81243492 | Pseudo-Gaucher cells in Hb E disease and thalassemia intermedia |
Q83979157 | Pseudobasophilia and the Advia 120 |
Q34234548 | Public health surveillance and data collection: general principles and impact on hemophilia care |
Q41745150 | Pulmonary hypertension in non-transfusion-dependent thalassemia: Correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron |
Q54215644 | Pulsatilla saponin A induces differentiation in acute myeloid leukemia in vitro. |
Q45353058 | Pure red cell aplasia associated with cytomegalovirus and Epstein-Barr virus infection in seven cases of Chinese children |
Q85900088 | Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis |
Q87896939 | Pyruvate Kinase Deficiency which Causes Nonspherocytic Hemolytic Anemia: The Gene and its Mutations |
Q86802957 | Quality of harvest and role of cell dose in unrelated bone marrow transplantation: an Italian Bone Marrow Donor Registry-Gruppo Italiano Trapianto di Midollo Osseo Study |
Q87426777 | Quantitative assessment of BAX transcript and flow cytometric expression in acute myeloid leukemia: a prospective study |
Q34780634 | Quantitative real-time PCR: a critique of method and practical considerations |
Q38958499 | Quercetin alleviates myocyte toxic and sensitizes anti-leukemic effect of adriamycin |
Q39477231 | Quercetin-induced apoptosis involves increased hTERT enzyme activity of leukemic cells |
Q50462438 | RBC alloimmunization and double alloantibodies in thalassemic patients. |
Q93099780 | RETRACTED ARTICLE: Retraction |
Q54982773 | RETRACTED: Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. |
Q39506861 | RITA enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis |
Q38778304 | ROS functions as an upstream trigger for autophagy to drive hematopoietic stem cell differentiation |
Q28393778 | Radiation exposure from diagnostic procedures following allogeneic stem cell transplantation--how much is acceptable? |
Q44353403 | Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma |
Q87910581 | Randomized Clinical Trial to Evaluate Maintenance Therapy in Diffuse Large Cell Lymphoma Treated with Intensive Chemotherapy |
Q39331020 | Rapid and inexpensive detection of common HBB gene mutations in Tunisian population by high-resolution melting analysis: implication for molecular diagnosis |
Q43083995 | Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD). |
Q80205146 | Rapid leukaemic evolution in a cutaneous blastic NK-cell lymphoma initially diagnosed as pseudolymphoma |
Q81243512 | Rapid transformation of atypical myeloproliferative disorder with consistent t(8;13) to B-cell acute lymphoblastic leukemia: a case report |
Q36270085 | Rationales for therapeutic apheresis |
Q91229171 | Re-personalization and stratification of hemophilia care in an evolving treatment landscape |
Q44640583 | Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft |
Q100951749 | Real-world analysis of treatment patterns and clinical outcomes in patients with newly diagnosed chronic lymphocytic leukemia from seven Latin American countries |
Q40896319 | Real-world outcome and healthcare costs of relapsed or refractory multiple myeloma: A retrospective analysis from the Chinese experience |
Q87911778 | Reasons to Eliminate Umbilical Cord Blood Units before Cryopreservation |
Q38894371 | Recent Advances in Bone Marrow Transplantation from Unrelated Volunteer Donors. |
Q36194575 | Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells |
Q36221526 | Recent thymic output function in patients with hematological malignancy |
Q45881838 | Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias |
Q33365354 | Recombinant activated factor VII in patients at high risk of bleeding |
Q45864633 | Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent |
Q81243488 | Recombinant human granulocyte colony-stimulating factor (rhG-CSF) promotes in vitro platelet aggregation |
Q42226584 | Recombinant human lipocalin 2 acts as an antibacterial agent to prevent platelet contamination. |
Q47815810 | Recommendations on the use of ruxolitinib for the treatment of myelofibrosis |
Q74816925 | Recovery of lymphocyte and dendritic cell subsets following reduced intensity allogeneic bone marrow transplantation |
Q53103287 | Recurrence patterns of mucose-associated lymphoid tissue lymphoma after definitive radiation treatment: A single center experience. |
Q44108320 | Recurrent acute myositis after allogeneic bone marrow transplantation for myelodysplasia |
Q50594822 | Red blood cell flags for the differential diagnosis between thalassemia trait and iron deficiency anemia. |
Q44446250 | Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India |
Q44108310 | Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia |
Q33397101 | Reduced corticosteroid use in adult patients with primary immune thrombocytopenia receiving romiplostim |
Q46981708 | Reduced serum retinol-binding protein levels in patients with de novo acute myeloid leukaemia |
Q87640404 | Reduced-intensity stem cell allografting for PNH patients in the eculizumab era: The Mexican experience |
Q46761942 | Reference percentiles of hematological and biochemical iron values of blood donors in Port Harcourt, Nigeria |
Q40643753 | Refractory Castleman's Disease |
Q115041145 | Refractory acquired thrombotic thrombocytopenic purpura in a patient with sickle cell trait successfully treated with caplacizumab |
Q40610270 | Regional Variations in the Further Management of Neutropenic Patients already Receiving Empirical Antimicrobial Therapy |
Q36269959 | Regulation and dysregulation of hematopoiesis by a cytokine-induced antiapoptotic molecule anamorsin |
Q40799492 | Regulation of LFA-1 Expression by CD34 Positive Cells and Inducible Growth Factor Production by Stroma Enable Formation of Bone Marrow Compartments; Subject Heading |
Q89572138 | Regulatory T cells and CD20+ B cells in pediatric very severe aplastic anemia: possible clinical markers for evaluating the therapeutic efficacy and prognosis |
Q38744187 | Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor |
Q87899110 | Relapsed Acute Lymphoblastic Leukemia Presenting as Optic Neuritis |
Q38992024 | Relation between glutathione S-transferase genes (GSTM1, GSTT1, and GSTP1) polymorphisms and clinical manifestations of sickle cell disease in Egyptian patients |
Q54570438 | Relationship Between Gestational Iron Deficiency and Iron Deficiency in the Newborn; Erythrocytes. |
Q39099149 | Relationship between JAK2V617F mutation, allele burden and coagulation function in Ph-negative myeloproliferative neoplasms |
Q54197606 | Relationship between SLCO1B3 and ABCA3 polymorphisms and imatinib response in chronic myeloid leukemia patients. |
Q36180564 | Relationship between cigarette smoking and risk of chronic myeloid leukaemia: a meta-analysis of epidemiological studies |
Q33431514 | Relationship between expression of glucocorticoid receptor isoforms and glucocorticoid resistance in immune thrombocytopenia |
Q43258160 | Relationship between expression of mutant type glutathione S-transferase theta-1 gene and reactivity of rapamycin in myelodysplastic syndrome |
Q57283957 | Relationship between genetic polymorphism of MTHFR C677T and lower extremities deep venous thrombosis |
Q43450491 | Relationship between maternal hemoglobin concentration and neonatal birth weight |
Q47214705 | Relationship between obesity and iron deficiency anemia: is there a role of hepcidin? |
Q57785626 | Relevance of antiphospholipid antibody profile in the clinical outcome of ITP: a single-centre study |
Q50555211 | Reliability of red blood cell indices and formulas to discriminate between beta thalassemia trait and iron deficiency in children. |
Q46045843 | Renal function in adult Jamaicans with homozygous sickle cell disease |
Q44648938 | Renal function in transfusion-dependent pediatric beta-thalassemia major patients |
Q51746881 | Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatment. |
Q48301582 | Repression of oxidative phosphorylation sensitizes leukemia cell lines to cytarabine |
Q38864887 | Research on the clinical effect and in vitro study of HLA-mismatched hematopoietic stem cell infusion for acute myeloid leukemia |
Q54325932 | Respiratory Failure and Intensive Care Support Following Bone Marrow Transplantation. |
Q88617853 | Response to letter: Wenle Zhao and Vance W. Berger, Better alternatives to permuted block randomization for clinical trials with unequal allocation |
Q44083412 | Response to low-dose desmopressin by a subcutaneous route in children with type 1 von Willebrand disease |
Q83304143 | Restricted TRBV repertoire in CD4+ and CD8+ T-cell subsets from CML patients |
Q87911781 | Results of a Controlled Clinical Trial Radiotherapy versus Combined Therapy in the Management of Stage IE Orbital Marginal Zone B-cell Lymphoma |
Q33381495 | Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia |
Q34329286 | Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest |
Q43950281 | Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation |
Q44543457 | Retrospective epidemiological study of Latin American patients with transfusional hemosiderosis: the first Latin American epidemiological study in iron overload--the RELATH study |
Q47965123 | Reversal of Life-Threatening Vascular Occlusion by Apheresis in Fulminating Plasmodium Falciparum Malaria |
Q35668684 | Reversal of MDR by verapamil analogues |
Q39476898 | Reverse hybridization StripAssay detection of beta-thalassemia mutations in northeast Egypt. |
Q45173516 | Reverse seroconversion of hepatitis B virus after allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease |
Q38673817 | Revisiting beta thalassemia intermedia: past, present, and future prospects. |
Q39090567 | Ribosomal protein S14 silencing inhibits growth of acute myeloid leukemia transformed from myelodysplastic syndromes via activating p53. |
Q58470546 | Risk factors for and prognosis of hemorrhagic cystitis after allogeneic stem cell transplantation: Retrospective analysis in a single institution |
Q93385633 | Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study |
Q51119875 | Risk factors for late-onset neutropenia after rituximab treatment of B-cell lymphoma. |
Q58596828 | Risk factors for venous thromboembolism (VTE) recurrences in Thai patients without cancer |
Q93042275 | Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis: a single-institution study of 171 Chinese patients |
Q40321913 | Risk factors of septic shock in patients with hematologic malignancies and Pseudomonas infections |
Q50759875 | Risky behaviours of Jamaican adolescents with sickle cell disease. |
Q84299396 | Rituximab based therapy followed by autologous stem cell transplantation leads to superior outcome and high rates of PCR negativity in patients with indolent B-cell lymphoproliferative disorders |
Q33400762 | Rituximab in the treatment of TTP. |
Q45327137 | Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung. |
Q33364313 | Rituximab is effective for selected patients with chronic steroid-refractory immune thrombocytopenic purpura |
Q37293515 | Rivaroxaban: future in anticoagulation practice? |
Q87879604 | Role of Soluble Interleukin-6 Receptor With Interleukin-6 in Human Hematopoiesis |
Q53587549 | Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly. |
Q54288880 | Role of co-inherited Gilbert syndrome on hyperbilirubinemia in Indian beta thalassemia patients. |
Q54365048 | Role of hERG1 K(+) channels in leukemia cells as a positive regulator in SDF-1a-induced proliferation. |
Q45421534 | Role of non-invasive assessment in prediction of preclinical cardiac affection in multi-transfused thalassaemia major patients. |
Q73390744 | Role of plasminogen activator inhibitor-1 (PAI-1) levels in the diagnosis of BMT-associated hepatic veno-occlusive disease and monitoring of subsequent therapy with defibrotide (DF) |
Q33384788 | Role of platelet volume indices in the differential diagnosis of thrombocytopenia: a simple and inexpensive method |
Q36308971 | Role of stem cell transplantation in myeloma |
Q89103079 | Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia |
Q33394562 | Romiplostin may revert the thrombocytopenia in graft-versus-host disease |
Q48168851 | Routine abdominal ultrasonography has limited value in the care for patients with indolent systemic mastocytosis |
Q55057300 | Routine application of a novel MLPA-based first-line screening test uncovers clinically relevant copy number aberrations in haematological malignancies undetectable by conventional cytogenetics. |
Q91053548 | Routine clinical care for chronic immune thrombocytopenia purpura in Denmark, 2009-2015 |
Q54491157 | SDF-1/CXCR4 signal is involved in decreased expression of p57kip2 in de novo MDS patients. |
Q33442438 | Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis |
Q40117299 | Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis |
Q86051320 | Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis |
Q87875744 | Sclerosing Mediastinitis Masquerading As A Lymphoma |
Q43083990 | Screening for glucose-6-phosphate dehydrogenase deficiency in blood donors |
Q50503683 | Screening of blood donors for erythrocyte alloantibodies. |
Q88750327 | Screening of prognostic risk microRNAs for acute myeloid leukemia |
Q51258001 | Screening of renal dysfunction among Burkitt lymphoma survivors by novel markers. |
Q50794138 | Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution. |
Q36069481 | Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia |
Q46364019 | Second malignancies in essential thrombocythemia (ET): a retrospective analysis of 331 patients with long-term follow-up from a single institution. |
Q87433768 | Secondary erythrocytosis |
Q40217390 | Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction |
Q44670178 | Selective apoptosis of multiple myeloma cells in primary samples induced by arsenic trioxide |
Q64984214 | Sensorineural hearing loss in children with sickle cell anemia and its association with endothelial dysfunction. |
Q54246693 | Sequence typing of human adenoviruses isolated from Polish patients subjected to allogeneic hematopoietic stem cell transplantation - a single center experience. |
Q74000732 | Sequential Variations in the Content of Bone Marrow Colony-forming Cells in Individual Patients with Aplastic Anemia Before and After Immunosuppressive Therapy; Hematopoiesis |
Q84917040 | Serum 25-hydroxyvitamin D levels are associated with prognosis in hematological malignancies |
Q87912683 | Serum Ferritin as Risk Factor for Veno-occlusive Disease of the Liver. Prospective Cohort Study |
Q74000779 | Serum Ferritin is a Reliable, Non-invasive Test for Iron Status in Pregnancy: Comparison of Ferritin with Other Iron Status Markers in a Longitudinal Study on Healthy Pregnant Women; Erythropoiesis |
Q87879587 | Serum Levels of Soluble CD 30 and Their Relationship to Tumour Burden and Prognosis in Patients with Hodgkin's Disease |
Q89547204 | Serum chitotriosidase: a circulating biomarker in polycythemia vera |
Q53565332 | Serum elastase and antithrombin-3 levels after umbilical cord blood transplantation or bone marrow transplantation. |
Q48165701 | Serum ferritin is a different predictor from transfusion history for allogeneic transplantation outcome in patients with severe aplastic anemia. |
Q81409260 | Serum leptin level in acute myeloid leukemia patients |
Q83063416 | Serum levels of endothelium-derived endocan are increased in patients with untreated acute myeloid leukemia |
Q81243470 | Serum levels, and bone marrow immunohistochemical expression of, vascular endothelial growth factor in patients with chronic myeloproliferative diseases |
Q92484155 | Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens |
Q84299415 | Serum prohepcidin in pulmonary tuberculosis |
Q33367291 | Severe gestational (incidental) thrombocytopenia: to treat or not to treat |
Q47693182 | Sex chromosome changes in leukemia: cytogenetics and molecular aspects. |
Q47684184 | Short Communication: Expression of Apoptosis Regulating Factors on T Lymphocytes in Multiple Myeloma Patients. |
Q87897569 | Short Report: Translation of Analysis Results between Serum Ferritin Assays, Ferritin RIA Amersham™ and Abbott AxSYM™ Ferritin |
Q33385546 | Should low-dose mycophenolate mofetil be used to prolong the response after rituximab therapy in patients with immune thrombocytopenic purpura? A case report |
Q80677037 | Should we test TPMT enzyme levels before starting azathioprine? |
Q57624600 | Sickle cell disease |
Q40109904 | Sickle cell disease in Madhya Pradesh, Central India: A comparison of clinical profile of sickle cell homozygote vs. sickle-beta thalassaemia individuals |
Q46214476 | Sickle cell disease in a carrier with pyruvate kinase deficiency. |
Q42790711 | Sickle cell disease serum induces NADPH enzyme subunit expression and oxidant production in leukocytes |
Q81271191 | Sickle cell disease: a multigenic perspective of a single gene disorder |
Q38847369 | Sickle cell/β-thalassemia: Comparison of Sβ0 and Sβ+ Brazilian patients followed at a single institution |
Q33369160 | Side effects of corticosteroid therapy in children with chronic idiopathic thrombocytopenic purpura |
Q38896241 | Signal Transduction by the Philadelphia Chromosome-encoded BCR/ABL Oncoproteins: Therapeutic Implications for Chronic Myeloid Leukemia and Philadelphia-positive Acute Lymphoblastic Leukemia |
Q54150547 | Signet-ring Cell Lymphoma-a Case Report. |
Q46399776 | Silent angiodysplasia and occult haemobilia as rare but treatable causes of refractory iron deficiency--two case reports |
Q87911400 | Similarity Between Multiple Sclerosis and Idiopathic Central Nervous System Dysfunction After Bone Marrow Transplantation |
Q74597221 | Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation |
Q40555233 | Similarity between hepatic graft-versus-host disease and primary biliary cirrhosis |
Q37234366 | Simulation of various randomization strategies for a clinical trial in sickle cell disease |
Q43083993 | Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia |
Q33405314 | Simultaneous romiplostin, eltrombopag, and prednisone were successful in severe thrombocytopenia of Evans syndrome refractory to hydrocortisone, splenectomy, intravenous IgG, and rituximab |
Q39573956 | Simultaneous targeting of P-gp and XIAP with siRNAs increases sensitivity of P-gp overexpressing CML cells to imatinib. |
Q28199044 | Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies |
Q33396252 | Single nucleotide polymorphism (SNP) analysis demonstrates a significant association of tumour necrosis factor-alpha (TNFA) with primary immune thrombocytopenia among Caucasian adults |
Q33433836 | Skin Necrosis Associated With Heparin-Induced Thrombocytopenia and Thrombosis |
Q74816942 | Skin infiltration with chronic lymphocytic leukemia is consistent with a good prognosis |
Q81018119 | Skin rash in a patient who underwent allogeneic bone marrow transplatation for AML |
Q36799626 | Skull bone infarctive crisis and deep vein thrombosis in homozygous sickle cell disease- case report and review of the literature |
Q38900001 | Slow and Steady Wins The Race? Progress in the Development of Vectors for Gene Therapy of β-Thalassemia and Sickle Cell Disease |
Q99602656 | Small PNH clones detected by fluorescent aerolysin predict a faster response to immunosuppressive therapy in patients with severe aplastic anaemia |
Q43235022 | Socio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results |
Q35670989 | Solitary plasmacytoma in the setting of Langerhans cell histiocytosis |
Q46231985 | Soluble P-selectin levels in diabetes mellitus patients with coronary artery disease |
Q42599546 | Soluble Receptors for Tumor Necrosis Factor and Neopterin as Parameters of Cell-Mediated Immune Activation |
Q46877293 | Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come. |
Q43838003 | Soluble hepatocyte growth factor (sHGF) and vascular endothelial growth factor (sVEGF) in adult acute myeloid leukemia: relationship to disease characteristics |
Q92484186 | Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis |
Q35552528 | Somatic hypermutation patterns in germinal center B cell malignancies |
Q47683086 | Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective |
Q74000827 | Specificity of Hematopoietic Stem and Progenitor Cell Homing to Bone Marrow: A Perspective; Subject Heading |
Q50645853 | Spectrum of diseases diagnosed on bone marrow examination of 285 infants in a single tertiary care center. |
Q37212363 | Spectrum of pure red cell aplasia in adult population of north-west India. |
Q33369401 | Splenectomy in haematology--a 5-year single centre experience |
Q38882070 | Splenic enlargement in adults with homozygous sickle cell disease: the Jamaican experience |
Q38541600 | Splenic infarction associated with sickle cell trait at low altitude |
Q82292954 | Splenic marginal zone lymphoma--a clinicopathological study in a series of 16 patients |
Q48331134 | Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era. |
Q79358893 | Splenic mass in a 42-year-old woman |
Q36269955 | Split-signal FISH for detection of chromosome aberrations. |
Q103838492 | Spontaneous recovery in a patient with acquired thrombotic thrombocytopenic purpura (TTP): observation of a 'subclinical' TTP state |
Q35126985 | Spontaneous regression of Hodgkin's disease: two case reports and a review of the literature |
Q46754921 | Stability of activated partial thromboplastin time (APTT) test under different storage conditions |
Q57770593 | Stage I-III Hodgkin's Disease: Outcome and Pattern of Failure Following Treatment with Radiation Therapy and Chemotherapy in a Modern Era |
Q62032120 | Statement of Retraction |
Q81344310 | Statement of duplicate publication |
Q54292567 | Status of 25-hydroxyvitamin D deficiency and effect of vitamin D receptor gene polymorphisms on bone mineral density in thalassemia patients of North India. |
Q34278296 | Stem Cell Transplantation for Chronic Lymphocytic Leukaemia: Is this the Way Forward in the New Millennium?; Malignancy; Current Clinical Practice |
Q56777940 | Stem cell plasticity |
Q44244814 | Stem cell transplantation for multiple myeloma: current and future status |
Q36269933 | Stem cell transplantation in multiple myeloma |
Q47679424 | Stigma and illness uncertainty: adding to the burden of sickle cell disease. |
Q47624338 | Stromal Cell Types: Characterization and Function In Situ and In Vitro |
Q89763229 | Students' knowledge on sickle cell disease in Kisangani, Democratic Republic of the Congo |
Q33425566 | Study of a humanized inhibitory anti-platelet glycoprotein VI phage antibody from a phage antibody library |
Q84289215 | Study of clinical and aetiological profile of 100 patients of pancytopenia at a tertiary care centre in India |
Q53540488 | Study of prognostic significance of marrow angiogenesis assessment in patients with de novo acute leukemia. |
Q40174632 | Sub classification and clinico-hematological correlation of 40 cases of acute erythroleukemia - can proerythroblast/myeloblast and proerythroblast/total erythroid cell ratios help subclassify? |
Q47684209 | Successful Cytoreduction with CAG (cytarabine, Aclarubicin and G-CSF) Therapy in Refractory Acute Myelogenous Leukemia before Allogeneic Stem Cell Transplantation |
Q44506531 | Successful bone marrow plus cord blood stem cell transplantation in a girl who developed myelodysplastic syndrome from hepatitis-associated aplastic anemia treated with long-term immunosuppressants and growth factors |
Q74627662 | Successful reduced-intensity stem cell transplant from one-locus HLA-mismatched unrelated cord blood after rejection of unrelated bone marrow in an infant with myelogenous leukemia |
Q53568893 | Successful reduced-intensity stem cell transplantation in a patient with myelodysplastic syndrome combined with Sweet's syndrome. |
Q44769904 | Successful treatment of aplastic variant of hairy-cell leukaemia with deoxycoformycin |
Q82292962 | Successful treatment of secondary hemophagocytic lymphohistiocytosis in a patient with disseminated histoplasmosis |
Q74816934 | Superior vena cava syndrome after bone marrow transplantation caused by aspergillosis: a case report |
Q36194555 | Survey of hematological aspects of Gaucher disease |
Q87911398 | Survival from Acute MyeloidLeukaemia in Patients Over 55 Years of Age in Northern Ireland: A Discrete Population |
Q87879597 | Susceptibility to Infection Due to Diminished Interferon-α-Producing Capacity in Patients with Refractory Anemia with Excess of Blasts or Refractory Anemia with Excess of Blasts in Transformation |
Q36270166 | Symptom management in hematological patients |
Q48070699 | Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma |
Q89012572 | Synchronous dual hematological malignancies: new or underreported entity? |
Q44545373 | Syndecan-1 in multiple myeloma: relationship to conventional prognostic factors |
Q88134514 | Synergistic effects of rmhTRAIL and 17-AAG on the proliferation and apoptosis of multiple myeloma cells |
Q35080315 | T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H). |
Q36687986 | T-large granular lymphocyte leukemia: current molecular concepts. |
Q92015401 | T-lymphocyte subsets and Th1/Th2 cytokines in convalescent patients with Epstein-Barr virus-associated aplastic anemia |
Q50599354 | TCR zeta chain expression in T cells from patients with CML. |
Q50002024 | TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells. |
Q88247979 | THE 36TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF HEMATOLOGY 2016 Glasgow 18(th) -21(st) April 2016 |
Q104141315 | Tacrolimus is effective in relapsed/refractory autoimmune cytopenias: results of a single-center retrospective study |
Q44772522 | Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia |
Q42717692 | Targeted inhibition of VEGF-modulated survival and arsenic sensitivity in acute myeloid leukemia (AML). |
Q92479972 | Targeted next-generation sequencing identified a novel ANK1 mutation associated with hereditary spherocytosis in a Chinese family |
Q36194545 | Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis |
Q54515803 | Targeted therapy of acute myeloid leukemia in 2012: towards individualized therapy. |
Q53172892 | Targeted therapy of multiple myeloma. |
Q90165293 | Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia |
Q64047404 | Tc99m-sestaMIBI uptake in nonsecretory multiple myeloma |
Q39305147 | TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients. |
Q46200205 | Technetium-99m Sestamibi Scanning Reflects Marrow Activity in a β-Thalassemia Patient Treated with an Allogeneic Bone Marrow Transplant |
Q87911045 | Technical Report: Triple-Colour Staining Flow Cytometry for Co-Distribution of Thrombospondin Receptor (CD36), Ribonucleic Acid (RNA) and Fetal Haemoglobin (HbF) in Sickle Red Blood Cells |
Q54609545 | Telomeres, Telomerase and Leukaemia. |
Q35668682 | Th1/Th2 cells in patients with multiple myeloma |
Q83903723 | Thalassemia |
Q33370469 | Thalassemia major-- on the verge of bleeding or thrombosis? |
Q40531242 | Thalidomide effects in the post-transplantation setting in patients with multiple myeloma |
Q48110343 | Thalidomide has a significant effect in patients with thalassemia intermedia. |
Q73634892 | Thalidomide in the management of multiple myeloma |
Q45204109 | The 5q- syndrome |
Q87912913 | The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease |
Q74000812 | The AML1/MTG8 Fusion Transcript in t(8;21) Positive AML and its Implication for the Detection of Minimal Residual Disease; Malignancy |
Q87879063 | The Diagnosis and Treatment of Iron Deficiency Anaemia |
Q87878291 | The Effect of Hemodialysis on the Expression of Platelet Glycoproteins Ib, IIb/IIIa and P-Selectin |
Q38984259 | The Egyptian experience with oral iron chelators |
Q87903575 | The Haematologist and the Infective Complications of HIV Infection |
Q87896936 | The Hematopoietic Microenvironment |
Q47622134 | The Hematopoietic Microenvironment. |
Q74000430 | The Hematopoietic Microenvironment: Heterogeneity of Bone Marrow Stromal Cells: Growth Properties and Cytokine Production by CD34+ and CD34- Stromal Sub-Sets |
Q74000622 | The Hematopoietic Microenvironment: Matrix Metalloproteinases in the Hematopoietic Microenvironment |
Q52134108 | The Hematopoietic Microenvironment: Osteoblasts and The Hematopoietic Microenvironment. |
Q74000504 | The Hematopoietic Microenvironment: Phenotypic and Functional Characterization of Human Marrow Vascular Stromal Cells |
Q74000423 | The Hematopoietic Microenvironment: Phylogeny and Ontogeny of the Hematopoietic Microenvironment |
Q74000497 | The Hematopoietic Microenvironment: Stromal Cell Types: Characterization and Function In Situ and In Vitro |
Q74000520 | The Hematopoietic Microenvironment: Stromal Extracellular Matrix Components As Growth Regulators For Human Hematopoietic Progenitors |
Q74000584 | The Hematopoietic Microenvironment: The Osteogenic Compartment of Bone Marrow: Cell Biology and Clinical Application |
Q40008183 | The Italian multiregional thalassemia registry: Centers characteristics, services, and patients' population |
Q87879580 | The Management of Essential Thrombocythaemia |
Q87879349 | The Management of Polycythaemia Vera |
Q81271216 | The Mexican approach to conduct allogeneic stem cell transplantation: braking dogmata and facing the Matthew effect |
Q38897747 | The Natural History of Hepatitis C Virus Infection in Hemophiliacs |
Q87912388 | The Number of Nucleoli and Main Nucleolar Types in Lymphoblasts of Children Suffering from Acute Lymphoid Leukemia |
Q87924337 | The Osteogenic Compartment of Bone Marrow: Cell Biology and Clinical Application |
Q38897750 | The Pathogenetic Role of Apoptosis in Hypercoagulable States |
Q87903567 | The Rationale for not Routinely Purging Autologous Blood Stem Cell Grafts |
Q42496148 | The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with Thrombocytosis |
Q54780723 | The Relevance of Circulating Interleukin-5 (IL-5) in Lymphoproliferative Disorders. |
Q47683876 | The Retinoblastoma Gene in Myeloid Leukaemias |
Q54151129 | The Role of Allogeneic Transplantation in the Treatment of Multiple Myeloma. |
Q46073592 | The Role of Inflammation and Leukocytes in the Pathogenesis of Sickle Cell Disease |
Q46054381 | The Role of Inflammation and Leukocytes in the Pathogenesis of Sickle Cell Disease; Haemoglobinopathy. |
Q38896599 | The Scope of Viral Vectors for the Transduction of Haemopoietic Cells |
Q38896186 | The Syndrome of Veno-occlusive Disease After Blood or Marrow Transplantation |
Q39870874 | The T-cell receptor Vbeta gene repertoire and clonal expansion from peripheral blood T cells in benzene-exposed workers in China |
Q81450840 | The TCR Vbeta repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen |
Q81018099 | The antiphospholipid syndrome |
Q90291773 | The association between antinuclear antibody and response to rituximab treatment in adult patients with primary immune thrombocytopenia |
Q104567091 | The association between pre-transfusion hemoglobin levels and thalassemia complications |
Q34160906 | The association between the copy-number variations of ZMAT4 and hematological malignancy |
Q53793130 | The association of cytokine genes polymorphisms and susceptibility to aplastic anemia in Egyptian patients. |
Q47806850 | The care of a child with multiple trauma and severe anemia who was a Jehovah's Witness |
Q92754913 | The challenges of handling deferasirox in sickle cell disease patients older than 40 years |
Q43485191 | The clinical and laboratory significance of cases of congenital FX deficiency due to defects in the Gla-domain |
Q54213442 | The clinical characteristics and therapy response of patients with acquired pure red cell aplasia. |
Q91035245 | The clinical outcomes of chronic myeloid leukemia patients harboring alternatively spliced BCR-ABL variants |
Q47292792 | The clinical significance of FLT3 ITD mutation on the prognosis of adult acute promyelocytic leukemia. |
Q33403270 | The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia |
Q91964056 | The clinical values of dysregulated DNA methylation and demethylation intermediates in acute lymphoblastic leukemia |
Q43014785 | The clinico-hematological profile of hairy cell leukaemia: a single centre experience |
Q45899996 | The cost of hematopoietic stem cell transplantation in the real world. |
Q98285819 | The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma |
Q38747300 | The diagnosis, prognosis, and therapeutic application of MicroRNAs in haematological malignancies |
Q96612073 | The diagnostic and prognostic value of MRI in central nervous system involvement of acute myeloid leukemia: a retrospective cohort of 84 patients |
Q36415999 | The effect of 5-hydroxtryptamine on the regulation of megakaryocytopoiesis |
Q48832311 | The effect of automated alerts on preoperative anemia management. |
Q45817965 | The effect of combined therapy with deferoxamine and deferiprone on serum ferritin level of beta-thalassemic patients |
Q43014781 | The effect of different ATG preparations on immune recovery after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia |
Q86084751 | The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia |
Q96612070 | The effect of rat nerve growth factor combined with vitamin B on peripheral neuropathy in multiple myeloma patients |
Q51759875 | The effect of storage on the clinical utility of the immature platelet fraction. |
Q46082575 | The effect of subclinical hypothyroidism on platelet parameters |
Q84965334 | The effect of the combination of bisphosphonates and conventional chemotherapy on bone metabolic markers in multiple myeloma patients |
Q36356141 | The effects of a data driven maximum surgical blood ordering schedule on preoperative blood ordering practices |
Q53589582 | The effects of iron treatment on viscosity in children with cyanotic congenital heart disease. |
Q91252062 | The effects of storage on platelet function in different blood products |
Q102064401 | The efficacy and adverse events of venetoclax in combination with hypomethylating agents treatment for patients with acute myeloid leukemia and myelodysplastic syndrome: a systematic review and meta-analysis |
Q53113161 | The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes. |
Q55052407 | The evaluation of the periodontium in patients with leukemia using thermographic imaging. |
Q35173179 | The evolving role of monoclonal antibodies and dendritic cell therapy in hematologic malignancies |
Q37639505 | The expanding spectrum of thalassemia intermedia. |
Q84429869 | The expression of LMO2 protein in acute B-cell and myeloid leukemia |
Q54365040 | The expression pattern of CD3 chain genes in fetal/maternal interface. |
Q33385552 | The feature of TRGV and TRDV repertoire distribution and clonality in patients with immune thrombocytopenic purpura |
Q82653376 | The flow-cytometric DNA content of the plasma cells of patients with multiple myeloma is a prognostic factor: a single institution experience |
Q36415991 | The genetics of the myelodysplastic syndromes: classical cytogenetics and recent molecular insights |
Q36069469 | The haematology of indigenous Australians |
Q92378390 | The imbalance between regulatory memory B cells reveals possible pathogenesis involvement in pediatric immune thrombocytopenia |
Q50216333 | The impact of FLT3 mutations on treatment response and survival in Chinese de novo AML patients. |
Q46979642 | The impact of Fc gamma receptor IIa and IIIa gene polymorphisms on the therapeutic response of rituximab in Egyptian adult immune thrombocytopenic purpura |
Q83903731 | The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL) |
Q46160587 | The impact of trisomy 12, retinoblastoma gene and P53 in prognosis of B-cell chronic lymphocytic leukemia |
Q81514979 | The impact on resources of prevalence and nature of skin problems in a modern intensive haemato-oncology practice |
Q36270014 | The importance of the protein C system in the pathogenesis of venous thrombosis |
Q90340861 | The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis |
Q46952184 | The intensive care management process in patients with hematopoietic stem cell transplantation and factors affecting their prognosis |
Q46364014 | The interaction between taxoids and serine/threonine protein phosphatase activities during taxan-induced apoptosis of HL 60 leukemic cells. |
Q53142140 | The level of peripheral blood circulating CD34+ cells is higher in acute promyelocytic leukemia patients with adverse prognostic factors. |
Q38525519 | The method of in vivo evaluation of hemostasis: Spatial thrombodynamics |
Q33368674 | The molecular basis of congenital thrombocytopenias: insights into megakaryopoiesis |
Q36270139 | The myelodysplastic syndromes: diagnosis, molecular biology and risk assessment |
Q47593550 | The outcome of haemopoietic stem cell transplantation in the treatment of lymphoplasmacytic lymphoma in the UK: a British Society Bone Marrow Transplantation study |
Q39851549 | The parallel application of karyotype interphase and metaphase FISH after DSP-30/IL-2 stimulation is necessary for the investigation of chronic lymphocytic leukemia |
Q80376729 | The plateled-derived growth factor level (PDGF) in Hodgkin's disease and non-Hodgkin's lymphoma and its relationship disease activation |
Q36194570 | The platelet-function analyzer (PFA-100) for evaluating primary hemostasis |
Q38003020 | The plurality of payers' perspectives on hematopoietic stem cell transplantation |
Q50646785 | The possible role of reticulocytes in sickle cell disease associated thromboembolism. |
Q47556784 | The potential association of CMV-specific CD8+ T lymphocyte reconstitution with the risk of CMV reactivation and persistency in post allogeneic stem cell transplant patients. |
Q48208737 | The potential association of tumor necrosis factor-βeta (252 G/A) cytokine gene polymorphism with immune thrombocytopenic purpura among Egyptian children |
Q103838491 | The predictive value of pre-treatment paroxysmal nocturnal hemoglobinuria clone on response to immunosuppressive therapy in patients with aplastic anemia: a meta-analysis |
Q50235213 | The preparation, characterization, and application of environment-friendly monoclonal antibodies for human blood cell. |
Q39288602 | The prevalence of G6PD deficiency in blood transfusion recipients. |
Q40800776 | The prevalence of alpha-thalassemia amongst Tai and Mon-Khmer ethnic groups residing in northern Thailand: A population-based study |
Q85493878 | The prevalence of the platelet glycoprotein VI polymorphisms in patients with sticky platelet syndrome and ischemic stroke |
Q104513289 | The prognostic impact of abnormally expressed, long noncoding RNAs in acute myeloid leukemia: a meta-analysis |
Q52669788 | The prognostic impact of long noncoding RNA HOTAIR in leukemia and lymphoma: a meta-analysis. |
Q49114034 | The prognostic impact of multiparameter flow cytometry immunophenotyping and cytogenetic aberrancies in patients with multiple myeloma. |
Q51969115 | The prognostic value of clinical and laboratory parameters in patients with chronic lymphocytic leukemia. |
Q45036513 | The proliferation arrest of primary tumor cells out-of-niche is associated with widespread downregulation of mitotic and transcriptional genes |
Q35552523 | The proteasome: a novel therapeutic target in haematopoietic malignancy |
Q81409270 | The proto-oncogene expression varies over the course of chronic myeloid leukemia |
Q38997520 | The questioning for routine monthly monitoring of proteinuria in patients with β-thalassemia on deferasirox chelation |
Q44944864 | The red cell distribution width (RDW): value and role in preterm, IUGR (intrauterine growth restricted), full-term infants. |
Q35605124 | The regulatory mechanism of IL-6-dependent proliferation of human myeloma cells |
Q89176459 | The relationship between gene polymorphism of MTRR A66G and lower extremity deep venous thrombosis |
Q89733757 | The relationship between interferon-gamma (INF-γ) single nucleotide polymorphism +874(T/A) and occurrence risk of aplastic anemia: a meta-analysis |
Q90463114 | The research progress of circular RNAs in hematological malignancies |
Q33368671 | The role of ADAMTS13 in the new pathogenesis of TTP. |
Q33406725 | The role of Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in immune thrombocytopenia |
Q46466632 | The role of anaemia in oxidative and genotoxic damage in transfused β-thalassaemic patients |
Q33442321 | The role of bone marrow microenvironment in platelet production and their implications for the treatment of thrombocytopenic diseases |
Q103720489 | The role of cystatin C as a proteasome inhibitor in multiple myeloma |
Q51102870 | The role of follicular T helper cells in patients with malignant lymphoid disease. |
Q38729618 | The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells |
Q38203927 | The role of notch signaling in bone marrow niche. |
Q39116002 | The role of rs1984112_G at CD36 gene in increasing reticulocyte level among sickle cell disease patients. |
Q39197389 | The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells |
Q46575243 | The roles of miR-146a in the differentiation of Jurkat T-lymphoblasts. |
Q89958934 | The safety of modern intravenous iron infusions in patients with rheumatoid arthritis - a review of the literature |
Q114098158 | The signature based on seven genomic instability-related genes could predict the prognosis of acute myeloid leukemia patients |
Q38083900 | The sticky platelet syndrome |
Q89492463 | The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study |
Q36269943 | The treatment of AML: current status and novel approaches |
Q38842954 | The treatment of CML at an environment with limited resources. |
Q45925774 | The tumour necrosis factor as a mediator of vessel inflammation: importance of exposed receptor residues for its neutralization. |
Q35668672 | The use of fluorescence in situ hybridization (FISH) in chronic lymphocytic leukemia (CLL). |
Q93244196 | The use of octagam and gammanorm in immunodeficiency associated with hematological malignancies: a prospective study from 21 French hematology departments |
Q53636425 | The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma. |
Q37183517 | The use of recombinant activated factor VII in platelet-associated bleeding |
Q81973595 | The use of short tandem repeat polymorphisms for monitoring chimerism following bone marrow transplantation: a short report |
Q43741190 | Therapeutic evaluation and prognostic value of interim hybrid PET/CT with (18)F-FDG after three to four cycles of chemotherapy in non-Hodgkin's lymphoma |
Q91128211 | Therapeutic options for adult patients with previously treated immune thrombocytopenia - a systematic review and network meta-analysis |
Q33394558 | Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center |
Q35809447 | Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment |
Q74000688 | Therapy: Hyperbaric Oxygen as the Only Effective Treatment in Mutilating and Resistant Systemic Vasculitis |
Q47838580 | Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature. |
Q33375518 | Thirty-nine cases of pure red cell aplasia: a single center experience from India |
Q33369162 | Thrombocytopenia due to cytomegalovirus infection in an immunocompetent adult |
Q33367297 | Thrombocytopenia in patients with severe acute respiratory syndrome (review). |
Q33433930 | Thrombocytopenia-Platelet Support or Growth Factors? |
Q87879809 | Thrombocytosis in Malignancy: A Paraneoplastic Syndrome? |
Q38897787 | Thromboelastography. |
Q48372138 | Thromboembolism following cesarean section: a retrospective study |
Q36761733 | Thromboembolism in childhood nephrotic syndrome: a rare but serious complication |
Q44097268 | Thromboembolism in patients on thalidomide for myeloma |
Q82834997 | Thrombomodulin and GFC levels in Legg-Calve-Perthes disease |
Q81271240 | Thrombophilia and pregnancy |
Q45343630 | Thrombophilia and varicella zoster in children |
Q46396319 | Thrombophilic DNA Mutations As Independent Risk Factors for Stroke and Avascular Necrosis in Sickle Cell Anemia |
Q48484275 | Thrombophilic gene mutations in children with migraine. |
Q33433774 | Thrombopoietic cytokines in patients with hepatitis C virus-associated immune thrombocytopenia. |
Q33365357 | Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia |
Q38897684 | Thrombopoietin Gene Regulation-A Review. |
Q50113572 | Thrombopoietin and its receptor expression in pediatric patients with chronic immune thrombocytopenia. |
Q33400774 | Thrombopoietin: too much or too little |
Q54338067 | Thrombosis and acute leukemia. |
Q38003019 | Thrombosis in multiple myeloma (MM). |
Q38003018 | Thrombosis in myeloproliferative and myelodysplastic syndromes |
Q45878587 | Thrombosis in rare bleeding disorders |
Q33400771 | Thrombosis in stem cell transplantation |
Q36415995 | Thrombotic complications in von Willebrand disease |
Q46214484 | Thrombotic complications of polycythemia vera |
Q33374370 | Thrombotic microangiopathies: an update |
Q78639201 | Thrombus formation with rehydrated, lyophilized platelets |
Q92276856 | Time course of peripheral blood count recovery during induction chemotherapy for childhood acute lymphoblastic leukemia |
Q36761725 | Timed-sequential chemotherapy as induction and/or consolidation regimen for younger adults with acute myelogenous leukemia |
Q51694454 | Tissue chimerism analysis after donor lymphocyte infusion: a case of deceptive evidence. |
Q47819163 | Tolerability and safety of the intravenous immunoglobulin octagam(®) 10% in patients with immune thrombocytopenia: a post-authorisation safety analysis of two non-interventional phase IV trials. |
Q73795173 | Total registration of non-Hodgkin's lymphoma and Hodgkin's disease in Scotland: effect of deprivation and caseload on outcome |
Q92837370 | Transcriptome analysis identifies key regulators and networks in Acute myeloid leukemia |
Q38849609 | Transforming growth factor 15 increased in severe aplastic anemia patients |
Q36270091 | Transfusion immunomodulation or TRIM: what does it mean clinically? |
Q36270080 | Treatment algorithms in CLL. |
Q36308975 | Treatment of AML in biological subgroups |
Q36307574 | Treatment of Epstein-Barr virus--associated lymphoproliferative disorder (EBV-PTLD) and pure red cell aplasia (PRCA) with Rituximab following unrelated cord blood transplantation: a case report and literature review |
Q87899106 | Treatment of Relapsing Ph+ Acute Lymphoblastic Leukemia with Donor Leukocyte Infusion Followed by Quantitative Monitoring of Residual Disease |
Q36270070 | Treatment of T-Cell lymphoma |
Q83903705 | Treatment of acquired aplastic anemia in children |
Q39103020 | Treatment of acute promyelocytic leukemia with PETHEMA LPA 99 protocol: a Tunisian single center experience |
Q50642217 | Treatment of alpha(0)-thalassemia (--(SEA)/--(SEA)) via serial fetal and post-natal transfusions: Can early fetal intervention improve outcomes? |
Q45952018 | Treatment of hairy cell leukemia: long-term results in a developing country. |
Q36269915 | Treatment of indolent lymphomas from watch and wait to high dose therapy |
Q34875188 | Treatment of lymphoid malignancies with non-myeloablative stem cell transplantation |
Q33374580 | Treatment of thrombotic microangiopathies with plasma exchange |
Q87896669 | Treatment of von Willebrand Disease |
Q36269910 | Treatment options in early stages of Hodgkin's Lymphoma, high cure rate with lower short and long-term toxicity |
Q41636233 | Treatment patterns and outcomes among patients with high-intermediate/high-risk diffuse large B-cell lymphoma in the USA. |
Q42790714 | Treatment related changes in antifibrinolytic activity in patients with polycythemia vera |
Q38980392 | Treatment with 5-Azacytidine improves clinical outcome in high-risk MDS patients in the 'real life' setting: A single center observational study |
Q58001055 | Trisomy 12 and t(14;22)(q32;q11) in a Patient with B-cell Chronic Lymphocytic Leukemia |
Q87876094 | Trisomy 12 is a Rare Event in Cases of CLL with Typical Immunophenotype and Morphology |
Q44146994 | Troxacitabine activity in extramedullary myeloid leukemia |
Q36844906 | Troxacitabine in acute leukemia |
Q36868592 | Troxacitabine in leukemia |
Q80559460 | Tuberculosis in acute leukemia: a clinico-hematological profile |
Q81973603 | Tumour necrosis factor and its receptor: a basic structural analysis of two counterparts |
Q54773736 | Type J CBFβ/MYH11 Transcript in the M4Eo Subtype of Acute Myeloid Leukemia |
Q61913814 | Ultrastructural analysis of platelets during three phases of pregnancy: A qualitative and quantitative investigation |
Q80559465 | Umbilical cord blood transplantation using non-myeloablative conditioning: the Mexican experience |
Q79839452 | Unbalanced bone turnover in children with beta-thalassemia |
Q89626939 | Understanding of the significance and health implications of asplenia in a cohort of patients with haemaglobinopathy: possible benefits of a spleen registry |
Q87879787 | Understanding the Graft-Versus-Leukaemia Reaction |
Q40673251 | Unexpected Epithelial Membrane Antigen (EMA) and Cytokeratin Expression in a Case of Infantile Acute Monoblastic Leukaemia |
Q50489416 | Unique red cell abnormality in a case of fatal methylene blue induced haemolysis. |
Q51801563 | Unusual extramedullary recurrences and breast relapse despite hepatic GVHD after allografting in Ph+-ALL. |
Q54482734 | Unusual location of BCR-ABL1 fusion sequences in a chronic myeloid leukemia patient. |
Q91736161 | Up to half of patients diagnosed with chronic lymphocytic leukemia in México may not require treatment |
Q104567046 | Up-regulated miR-155 is associated with poor prognosis in childhood acute lymphoblastic leukemia and promotes cell proliferation targeting ZNF238 |
Q36269919 | Update on lymphoma management: diffuse large B-cell NHL. |
Q35809195 | Update on the treatment of disseminated intravascular coagulation |
Q91971227 | Upfront autologous hematopoietic stem cell transplantation in patients with high-risk stage III to IV Hodgkin lymphoma: a multicenter retrospective cohort study |
Q53864352 | Upon drug-induced apoptosis expression of prostate-apoptosis-response-gene-4 promotes cleavage of caspase-8, bid and mitochondrial release of cytochrome c. |
Q38843959 | Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma |
Q46413575 | Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia |
Q81243508 | Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance |
Q79358883 | Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion |
Q87896118 | Use of Bisphosphonates in the Treatment of Multiple Myeloma |
Q51759871 | Use of HbA estimation by CE-HPLC for prenatal diagnosis of beta-thalassemia; experience from a tertiary care centre in north India: a brief report. |
Q84787075 | Use of continuous venovenous hemofiltration for acute renal failure due to multiple myeloma cast nephropathy |
Q57098520 | Use of cryoprotectant-depleted allogeneic peripheral blood stem cells for transplantation |
Q93050001 | Use of decitabine for patients with refractory or relapsed acute myeloid leukemia: a systematic review and meta-analysis |
Q45988194 | Use of imatinib mesylate in elderly patients in Northern Ireland: evidence of comparable haematological and molecular responses to younger patients. |
Q46374598 | Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease |
Q33370467 | Use of rituximab in refractory autoimmune thrombocytopenia following an autologous stem cell transplant |
Q46712150 | Usefulness of red blood cell flags in diagnosing and differentiating thalassemia trait from iron-deficiency anemia. |
Q87901917 | Uses of Column Technology in Blood Transfusion |
Q47562573 | Utility of mean sphered cell volume and mean reticulocyte volume for the diagnosis of hereditary spherocytosis |
Q37293519 | Utility of subsequent conventional dose chemotherapy in relapsed/refractory transplant-eligible patients with diffuse large B-cell lymphoma failing platinum-based salvage chemotherapy. |
Q39078119 | VEGF depletion enhances bcr-abl-specific sensitivity of arsenic trioxide in chronic myelogenous leukemia |
Q39337509 | Valproic acid inhibits proliferation of EB virus-infected natural killer cells |
Q38015946 | Value of 18FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience |
Q48561018 | Value of speckle tracking echocardiography for detection of clinically silent left ventricular dysfunction in patients with β-thalassemia. |
Q87426764 | Values of mean cell volume and mean sphered cell volume can differentiate hereditary spherocytosis and thalassemia |
Q36497387 | Venous thrombosis associated with pernicious anaemia. A report of two cases and review |
Q40387597 | Vincristine resistance development in lymphoblastoid cells under conditions of selective P-glycoprotein inhibition |
Q43785371 | Viral lymphomas: can antivirals be used to treat cancer? |
Q36270026 | Virtual microscopy: applications to hematology education and training |
Q87450132 | Von Willebrand disease |
Q51607495 | Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosis. |
Q97541013 | Vulnerability of sickle cell disease persons to the COVID-19 in sub-Saharan Africa |
Q89980410 | WT1 overexpression predicted good outcomes in adult B-cell acute lymphoblastic leukemia patients receiving chemotherapy |
Q36269963 | WT1 overexpression: a clinically useful marker in acute and chronic myeloid leukemias |
Q33400766 | Waldenström macroglobulinemia. |
Q43173269 | Whither the bone marrow transplant? |
Q87878289 | Why Collaboration is Necessary Between Worldwide Bone Marrow Registries |
Q92837397 | Wilms' tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children? |
Q83304136 | Wilms' tumor protein and FLT3-internal tandem duplication expression in patients with de novo acute myeloid leukemia |
Q45173841 | XPD gene polymorphisms and the effects of induction chemotherapy in cytogenetically normal de novo acute myeloid leukemia patients |
Q93183696 | Yttrium-90 ibritumomab tiuxetan consolidation versus rituximab maintenance therapy after induction chemotherapy in patients with indolent non-Hodgkin lymphoma: a single-institution experience |
Q36194583 | Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment |
Q53301647 | c-Myc oncogene and Cdc25A cell activating phosphatase expression in non-Hodgkin's lymphoma. |
Q53145261 | mRNA expression and promoter DNA methylation status of CDKi p21 and p57 genes in ex vivo expanded CD34 (+) cells following co-culture with mesenchymal stromal cells and growth factors. |
Q90694242 | miR-29b inhibits the progression of multiple myeloma through downregulating FOXP1 |
Q46716752 | rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients. |
Q52934047 | rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients. |
Q39355494 | shRNA-Mediated BAALC knockdown affects proliferation and apoptosis in human acute myeloid leukemia cells |
Q80677012 | t(14;18)(q32;q21)-bearing pleural MALT lymphoma with IgM paraproteinemia: value of detection of specific cytogenetic abnormalities in the differential diagnosis of MALT lymphoma and lymphoplasmacytic lymphoma |
Q79840229 | t(8;16) AML developed subsequent to breast cancer therapy |
Q79441310 | t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience |
Q48269594 | β(S) globin gene haplotype and the stroke risk among Egyptian children with sickle cell disease |
Search more.